UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


Form 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended March 31, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from ____ to _____

Commission file number: 1-16525

 

CVD EQUIPMENT CORPORATION

 

(Name of Registrant in Its Charter)

 

New York

11-2621692

   

State or Other Jurisdiction of
Incorporation or Organization)

(I.R.S. Employer Identification No.)

 

355 South Technology Drive Central

Islip, New York 11722

 

 

(Address of principal executive offices)

 

(631) 981-7081
(Registrants Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

CVV

NASDAQ Capital Market

 

Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑   No☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑   No☐

 

Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer   ☐            

Accelerated filer   ☐

 

Non-accelerated filer      ☑             

Smaller reporting company      ☑ 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                                     ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

  Yes  ☐      No  ☑

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 6,684,281 shares of Common Stock, $0.01 par value at May 7, 2021.

 

 

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

 

 

Index

 

Part I - Financial Information  

Item 1 – Condensed Consolidated Financial Statements (Unaudited)

 
   

Condensed Consolidated Balance Sheets at March 31, 2021 and December 31, 2020

3

   

Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020

4

   

Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2021 and 2020

5

   

Condensed Consolidated Statements of Cash Flows for the three months  ended March 31, 2021 and 2020

6

   

Notes to Condensed Consolidated Financial Statements

7

   

Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

29

Item 4 – Controls and Procedures

29

   

Part II - Other Information

 
   

Item 1 – Legal Proceedings

30

Item 1A-Risk Factors

30

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

30

Item 3 – Defaults Upon Senior Securities

30

Item 4 – Mine Safety Disclosures

30

Item 5 – Other Information

30

Item 6 – Exhibits

30

   

Signatures

32

   

Exhibit Index

33

 

2

 

 

PART 1 – FINANCIAL INFORMATION

Item 1 – Financial Statements

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

 

    (Unaudited)          
   

March 31, 2021

   

December 31, 2020

 

ASSETS

               

Current Assets

               

Cash and cash equivalents

  $ 5,929,363     $ 7,699,335  

Accounts receivable, net

    819,030       1,047,728  

Contract assets

    1,027,288       494,281  

Inventories, net

    1,340,000       1,123,839  

Taxes Receivable

    715,599       715,599  

Other current assets

    447,618       709,175  

Assets held for sale

    16,181,368       -  

Total Current Assets

    26,460,266       11,789,957  
                 

Property, plant and equipment, net

    12,460,305       28,843,563  
                 

Intangible assets, net

    261,645       288,657  

Other assets

    23,318       13,748  

Total Assets

  $ 39,205,534     $ 40,935,925  
                 
                 

LIABILITIES AND STOCKHOLDERS EQUITY

               

Current Liabilities

               

Accounts payable

  $ 503,309     $ 817,933  

Accrued expenses

    1,673,162       1,409,039  

Current maturities of long-term debt

    1,990,508       690,667  

Contract Liabilities

    733,507       786,657  

Liabilities held for sale

    9,218,683       -  

Total Current Liabilities

    14,119,169       3,704,296  
                 

Long-term debt, net of current portion

    2,415,970       13,106,057  
                 

Total Liabilities

    16,535,139       16,810,353  
                 

Commitments and contingencies (see note 13)

               
                 

Stockholders’ Equity:

               

Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding 6,684,281 at March 31, 2021 and 6,678,698 at December 31, 2020

    66,842       66,786  

Additional paid-in capital

    27,012,001       26,961,684  

Accumulated deficit

    (4,408,448 )     (2,902,898 )

Total Stockholders’ Equity

    22,670,395       24,125,572  
                 

Total Liabilities and Stockholders’ Equity

  $ 39,205,534     $ 40,935,925  

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

3

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)

 

   

Three Months Ended

 
   

March 31,

 
   

2021

   

2020

 
                 

Revenue

  $ 3,365,860     $ 6,036,360  
                 

Cost of revenue

    3,047,280       4,100,836  
                 

Gross profit

    318,580       1,935,524  
                 

Operating expenses

               

Research and development

    100,432       113,828  

Selling and shipping

    135,755       165,777  

General and administrative

    1,701,180       1,547,758  
                 

Total operating expenses

    1,937,367       1,827,363  
                 

Operating (loss) income

    (1,618,787 )     108,161  
                 

Other income (expense):

               

Interest income

    1,223       24,902  

Interest expense

    (107,221 )     (116,038 )

Other Income

    219,235       110,809  

Total other income, net

    113,237       19,673  
                 

(Loss) income before income tax

    (1,505,550 )     127,834  
                 

Income tax (benefit)

    -       (1,530,644 )
                 

Net (loss) income

  $ (1,505,550 )   $ 1,658,478  
                 
                 

Basic (loss) income per common share

  $ (0.23 )   $ 0.25  

Diluted (loss) income per common share

  $ (0.23 )   $ 0.25  
                 

Weighted average common shares Outstanding-basic

    6,680,130       6,626,036  
                 

Weighted average common shares Outstanding-diluted

    6,680,130       6,626,036  

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

4

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

Three months ended March 31, 2021 and 2020

                                 
   

Common stock

                         
   

 

 

   

 

   

Additional

   

Retained

Earnings /

   

 

 

 
    Shares    

Par

Value

   

paid-in

Capital

   

(Accumulated

deficit)

    Total  
                                         
                                         
                                         

Balance at January 1, 2021

    6,678,698     $ 66,786     $ 26,961,684     $ (2,902,898 )   $ 24,125,572  

Net loss

    -       -       -       (1,505,550 )     (1,505,550 )

Share-Based Compensation

    5,583       56       50,317       -       50,373  

Balance at March 31, 2021

    6,684,281     $ 66,842     $ 27,012,001     $ (4,408,448 )   $ 22,670,395  
                                         

Balance at January 1, 2020

    6,623,793     $ 66,237     $ 26,719,554     $ 3,172,054     $ 29,957,845  

Net income

    -       -       -       1,658,478       1,658,478  

Share-Based Compensation

    9,562       96       72,552       -       72,648  

Balance at March 31, 2020

    6,633,355     $ 66,333     $ 26,792,106     $ 4,830,532     $ 31,688,971  

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

5

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   

Three Months Ended

 
   

March 31,

 
   

2021

   

2020

 

Cash flows from operating activities:

               

Net (loss) income

  $ (1,505,550 )   $ 1,658,478  

Adjustments to reconcile net (loss) income to net cash (used in) operating activities

               

Stock-based compensation

    50,373       72,648  

Depreciation and amortization

    255,644       327,540  

(Increase)/decrease in operating assets

               

Accounts receivable

    228,699       (692,719 )

Contract assets

    (533,007 )     (1,240,143 )

Inventories

    (216,160 )     19,146  

Tax receivable

    -       (1,528,305 )

Other current assets

    251,987       200,980  

Increase/(decrease) in operating liabilities

               

Accounts payable

    (314,625 )     201,587  

Accrued expenses

    264,123       (422,268 )

Contract liabilities

    (53,150 )     727,818  

Total adjustments

    (66,116 )     (2,333,716 )

Net cash used in operating activities

    (1,571,666 )     (675,238 )
                 

Cash flows from investing activities:

               

Capital expenditures

    (26,744 )     (422,435 )

Net cash used in investing activities

    (26,744 )     (422,435 )
                 

Cash flows from financing activities

               

Payments of long-term debt

    (171,562 )     (166,878 )

Net cash (used) in financing activities

    (171,562 )     (166,878 )
                 

Net decrease in cash and cash equivalents

    (1,769,972 )     (1,264,551 )
                 

Cash and cash equivalents at beginning of period

    7,699,335       8,664,253  
                 

Cash and cash equivalents at end of period

  $ 5,929,363     $ 7,399,702  
                 

Supplemental disclosure of cash flow information:

               

Income taxes paid

  $ -     $ -  

Interest paid

  $ 106,547     $ 115,852  

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

6

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(unaudited)

 

 

NOTE 1:         

 

BASIS OF PRESENTATION

 

The accompanying unaudited condensed consolidated financial statements for CVD Equipment Corporation and Subsidiaries (collectively “the Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. They do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary in order to make the interim financials not misleading have been included and all such adjustments are of a normal recurring nature. The operating results for the three months ended March 31, 2021 are not necessarily indicative of the results that can be expected for the year ending December 31, 2021.

 

The condensed consolidated balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at such date, as filed on Form 10-K with the SEC on March 31, 2021, but does not contain all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with that report.

 

All material intercompany balances and transactions have been eliminated in consolidation. In addition, certain reclassifications have been made to prior period consolidated financial statements to conform to the current period presentation.

 

 

BUSINESS DEVELOPMENTS

 

In January 2021, the Board of Directors made a decision to implement a change in direction and new leadership to evaluate the business strategy and operations. As such, they appointed Emmanuel Lakios as President and Chief Executive Officer (previously our Vice-President- Sales and Marketing). Subsequent to this, a decision was made based on continued losses and significant investments required to continue in the Materials business that our primary focus should be on the core equipment business and that the Materials Business strategy should be revised, with some of its current elements potentially minimized or ceased.  Based upon an analysis, including forecasted continued losses and negative cash flows for the Tantaline product line, the Company has implemented plans to eliminate further investment in our Tantaline product line. In addition, we have recorded an impairment charge of $3.6 million during the fourth quarter and year ended December 31, 2020. In addition, the Company continues to monitor its costs and will take actions to mitigate expenses in the future to align them with anticipated revenue levels.

 

7

 

NOTE 1: (continued)

 

In order to increase the Company’s liquidity and to provide necessary working capital to support the Company’s on-going business and operations, the Board has decided to sell the 555 Building in February 2021. Management has determined the 555 Building is not needed for present and future business operations and concluded that any remaining elements of the Materials Business can be consolidated into the 355 Building, which it believes can accommodate any needs for our growth for the foreseeable future. In April 2021, the Company completed the move of its Tantaline product line to the 355 Building, while the MesoScribe consolidation into the 355 Building has been initiated.

 

On March 29, 2021, the Company entered into an agreement with Steel K, LLC for the sale of its 555 Building. The purchase price is $24,360,000, and the closing of the sale is subject to the satisfaction or waiver of certain conditions to closing or contingencies. A portion of the sale proceeds would be used to satisfy the existing mortgage debt on the 555 Building in the approximate amount of $9.2 million at March 31, 2021, and for various costs related to the sale closing in an amount to be determined. Any excess proceeds will be used for general working capital purposes. On or about May 23, 2021, the buyer may advise the Company of any requirement to extend the closing date up to 60 days thereafter.

 

 

 

NOTE 2:         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

The Company designs, manufactures and sells custom chemical vapor deposition equipment through contractual agreements. These system sales require the Company to deliver functioning equipment that is generally completed within three to eighteen months from commencement of order acceptance. The Company recognizes revenue over time by using an input method based on costs incurred as it depicts the Company’s progress toward satisfaction of the performance obligation. Under this method, revenue arising from fixed price contracts is recognized as work is performed based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligations, typically within three months to eighteen months.

 

8

 

NOTE 2:         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Revenue Recognition (continued)

 

Incurred costs include all direct material and labor costs and those indirect costs related to contract performance, such as supplies, tools, repairs and depreciation costs. Contract material costs are included in incurred costs when the project materials have been purchased or moved to work in process, and installed, as required by the project’s engineering design. Cost based input methods of revenue recognition require the Company to make estimates of costs to complete the projects. In making such estimates, significant judgment is required to evaluate assumptions related to the costs to complete the projects, including materials, labor and other system costs. If the estimated total costs on any contract are greater than the net contract revenues, the Company recognizes the entire estimated loss in the period the loss becomes known and can be reasonably estimated.

 

“Contract assets,” include unbilled amounts typically resulting from system sales under contracts and revenue recognized exceeds the amount billed to the customer. The amount may not exceed their estimated net realizable value. Contract assets are classified as current based on our contract operating cycle.

 

“Contract liabilities,” include advance payments and billings in excess of revenue recognized. The Company typically receives down payments upon receipt of order and progress payments during the manufacturing cycle. Contract liabilities are classified as current based on our contract operating cycle and reported on a contract-by-contract basis, net of revenue recognized, at the end of each reporting period.

 

For outright sales of products, revenue is recognized when control of the promised products or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606, “Revenue from Contracts with Customers”.

 

 

Recent Accounting Standards

 

In June 2016, the FASB issued Accounting Standard Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326), which require that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increase or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. On November 15, 2019, the FASB delayed the effective date for smaller reporting companies. The amendments in this update are now effective for fiscal years beginning after December 15, 2022 and interim periods within those annual periods. Early adoption for fiscal years beginning after December 15, 2018 is permitted. We are currently evaluating the effect of this update on our consolidated financial statements.

 

9

 

NOTE 2:         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Recent Accounting Standards (continued)

 

We believe there is no additional new accounting guidance adopted, but not yet effective that is relevant to the readers of our financial statements. However, there are numerous new proposals under development which, if and when enacted, may have a significant impact on our financial reporting.

 

 

 

NOTE 3:         CONCENTRATION OF CREDIT RISK

 

Cash and cash equivalents

 

The Company had cash and cash equivalents of $5.9 million and $7.7 million at March 31, 2021 and December 31, 2020, respectively. The Company invests excess cash in U.S. treasury bills, certificates of deposit or money market accounts, all with original maturities of less than three months. Cash equivalents were $1.0 million at March 31, 2021 and December 31, 2020, respectively.

 

The Company places most of its temporary cash investments with financial institutions, which from time to time may exceed the Federal Deposit Insurance Corporation limit. The amount at risk at March 31, 2021 and December 31, 2020 was $3,677,000 and $5,822,000, respectively.

 

Sales concentration

 

Revenue from a single customer in any one period can exceed 10% of our total revenues. During the three months ended March 31, 2021, one customer exceeded 10%, and represented 30.7% of revenues. During the three months ended March 31, 2020, three customers exceeded 10%, and represented 27.1%, 21.5% and 19.3% of revenues, respectively.

 

Accounts receivable

 

The Company sells products and services to various companies across several industries in the ordinary course of business. The Company performs ongoing credit evaluations to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience, evaluation of their credit history and review of the invoicing terms of the contract to determine the financial strength of its customers. The Company also maintains allowances for anticipated losses. At March 31, 2021, two customers exceeded 10% of the accounts receivable balance, representing 25.1% in total, and at December 31, 2020 two customers represented 35.0% of the accounts receivable balance.

 

10

 

 

NOTE 4:         REVENUE DISAGGREGATION

 

The following table represents a disaggregation of revenue for the three months ended March 31, 2021 and 2020 (in thousands):

 

   

Three Month's Ending March 31, 2021

 
                         
   

Over time

   

Point in time

   

Total

 

Aerospace

  $ 189     $ 526     $ 715  

Industrial

  $ 1,369     $ 675     $ 2,044  

Research

  $ 187     $ 420     $ 607  

Total

  $ 1,745     $ 1,621     $ 3,366  

 

 

   

Three Month's Ending March 31, 2020

 
                         
   

Over time

   

Point in time

   

Total

 

Aerospace

  $ 1,165     $ 2,185     $ 3,350  

Industrial

  $ 127     $ 861     $ 988  

Research

  $ 594     $ 1,104     $ 1,698  

Total

  $ 1,886     $ 4,150     $ 6,036  

 

 

The Company has unrecognized contract revenue of approximately $1.7 million at March 31, 2021, which it expects to recognize as revenue within the next twelve months.

 

Judgment is required to evaluate assumptions including the amount of net contract revenues and the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize.

 

Changes in estimates for sales of systems occur for a variety of reasons, including but not limited to (i) build accelerations or delays, (ii) product cost forecast changes, (iii) cost related change orders or add-ons, or (iv) changes in other information used to estimate costs. Changes in estimates may have a material effect on the Company’s consolidated statements of operations.

 

11

 

NOTE 4:         REVENUE DISAGGREGATION (continued)

 

Contract Assets and Liabilities

 

Contract assets consist of (i) retainage which represent the earned, but unbilled, portion for which payment is deferred by the customer until certain contractual milestones are met; and (ii) unbilled receivables which represent revenue that has been recognized in advance of billing the customer, which is common for long-term contracts. Contract liabilities consist of customer advances and billings in excess of revenue recognized.

 

During the three months ended March 31, 2021 and 2020, the increase in contract assets of approximately $.5 million and $1.2 million, respectively, was the result of work performed in excess of billings which are based upon project milestones.

 

Contract assets and contract liabilities on input method type contracts in progress are summarized as follows:

 

   

2021

 

Costs incurred on contracts in progress

  $ 5,266,960  

Estimated earnings

    2,503,933  
      7,770,893  

Billings to date

    (6,867,896 )
    $ 902,997  

Deferred revenue related to non-systems contracts

    (609,216 )
      293,781  

Included in accompanying balance sheets

       

Under the following captions:

       

Contract assets

  $ 1,027,288  

Contract liabilities

  $ (733,507 )

 

 

 

NOTE 5:          INVENTORIES, NET

 

Inventories consist of:

               
   

March 31,

2021

   

December 31,

2020

 
                 

Raw materials

  $ 1,059,663     $ 928,221  

Work-in-process

    280,337       195,618  

Inventories

  $ 1,340,000     $ 1,123,839  

 

 

 

NOTE 6:         ACCOUNTS RECEIVABLE, NET

 

Accounts receivable are presented net of an allowance for doubtful accounts of approximately $164,000 as of March 31, 2021 and December 31, 2020. The allowance is based on prior experience and management’s evaluation of the collectability of accounts receivable. Management believes the allowance is adequate. However, future estimates may change based on changes in future economic conditions.

 

 

NOTE 7:         LONG-TERM DEBT

 

The Company has a loan agreement with HSBC which is secured by a mortgage against our Central Islip, NY headquarters. The loan is payable in 120 consecutive equal monthly installments of $25,000 in principal plus interest and a final balloon payment upon maturity in March 2022. The balances as of March 31, 2021 and December 31, 2020 were approximately $2.0 million and $2.1 million respectively. Interest accrues on the loan, at our option, at the variable rate of LIBOR plus 1.75% or Prime less 0.5% (1.86% and 1.89% at March 31, 2021 and December 31, 2020, respectively).

 

12

 

NOTE 7:         LONG-TERM DEBT (continued)

 

On November 30, 2017, the Company purchased the premises located at 555 North Research Place, Central Islip, NY. The purchase price of the building was $13,850,000 exclusive of closing costs. The Company’s wholly-owned subsidiary, 555 N Research Corporation (the “Assignee”) and the Islip IDA, entered into a Fee and Leasehold Mortgage and Security Agreement (the ”Loan”) with HSBC in the amount of $10,387,500, which was used to finance a portion of the purchase price to acquire the premises located at 555 North Research Place, Central Islip, New York. The Loan was evidenced by the certain note, dated November 30, 2017 (the “Note”), by and between Assignee and the Bank, and secured by a certain Fee and Leasehold Mortgage and Security Agreement (the “Mortgage”), dated November 30, 2017, as well as a collateral Assignment of Leases and Rents.

 

The Note is payable in 60 consecutive equal monthly installments of $62,481 including interest and a final balloon payment upon maturity in December 2022. The balance outstanding as of March 31, 2021 and December 31, 2020 were approximately $9.2 million and $9.3 million respectively. The Note bears interest for each Interest Period (as defined in the Note), at the fixed rate of 3.9148%. As a condition of the Bank making the Loan, the Company was required to guaranty Assignee’s obligations under the Loan pursuant that certain Unlimited Guaranty, dated November 30, 2017 (the “Guaranty”). As of March 31, 2021, the full amount of this Note is recorded as Liabilities Held For Sale (see Note 8).

 

On August 5, 2019, the Company entered into a Mortgage Modification Agreement which replaced the former covenant with a Minimum Liquid Assets (“MLC”) covenant, and on October 22, 2020, the Company entered into a Second Mortgage Modification Agreement modifying certain MLC balances. The Company is in compliance with its financial covenant under the mortgage at March 31, 2021.

 

On April 21, 2020, the Company entered into a loan agreement (the “Loan Agreement”) with HSBC Bank USA, National Association pursuant to which the Company was granted a loan in the principal amount of $2,415,970, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted by the United States Congress on March 27, 2020.

 

The PPP loan, the obligation of which is represented by a note issued by the Company, matures on April 21, 2022 and bears interest at a rate of 1% per annum. The note may be prepaid by the Company at any time prior to maturity with no prepayment penalties. Under the terms of the PPP, all or a portion of the Loan may be forgiven, based upon payments made in the first twenty-four weeks following receipt of the proceeds, related to payroll costs, continue group health care benefits, utilities and mortgage interest on other debt obligations incurred before February 15, 2020. The Company has filed an application for forgiveness in April 2021, and anticipates all or substantially all of the PPP loan to be forgiven.

 

13

 

 

NOTE 8: ASSET AND LIABILITIES HELD FOR SALE

 

In order to increase the Company’s liquidity and to provide necessary working capital to support its on-going business and operations, the Company is selling the 555 Building. Management has determined the 555 Building is not needed for present and future business operations, and any remaining elements of the Materials Business can be consolidated into the 355 Building, which management believes can accommodate any needs for the Company’s growth for the foreseeable future.

 

On March 29, 2021, the Company entered into an agreement with Steel K, LLC for the sale of the 555 Building. The purchase price is $24,360,000, and the closing of the sale is subject to the satisfaction or waiver of certain conditions to closing or contingencies. A portion of the sale proceeds would be used to satisfy the existing mortgage debt on the 555 Building in the approximate amount of $9.2 million at March 31, 2021, and for various costs related to the sale closing in an amount to be determined. The excess proceeds will be used for general working capital purposes. As a result, the Company has classified the carrying value of the building of $16.2 million as Assets held for sale (which was utilized by CVD Materials) as part of current assets at March 31, 2021, which were previously recorded at December 31, 2020 and prior as part of property, plant and equipment on the Company’s consolidated balance sheet.

 

In addition, the Note related to the 555 Building was classified as part of current liabilities at March 31, 2021, Liabilities Held For Sale in the amount of $9.2 million, which were previously recorded at December 31, 2020 and prior as part of both current and long term debt on the Company’s consolidated balance sheet.

 

 

 

NOTE 9:         STOCK-BASED COMPENSATION EXPENSE

 

The Company recorded as part of general and administrative expense $44,000 and $73,000 during the three months ended March 31, 2021 and 2020, respectively, for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments.

 

14

 

NOTE 9:         STOCK-BASED COMPENSATION EXPENSE (continued)

 

A summary of the stock option activity related to the 2001 Stock Option Plans, the 2007 Share Incentive Plan and the 2016 Share Incentive Plan for the period from January 1, 2021 through March 31, 2021 are as follows:

 

2001 Non-Qualified Stock Option Plan

                                         
   

Beginning

   

Granted

   

Exercised

   

Canceled

   

Ending

         
   

Balance

   

During

   

During

   

During

   

Balance

         
   

Outstanding

   

Period

   

Period

   

Period

   

Outstanding

   

Exercisable

 
                                                 

Number of shares

    7,000       -       -       (7,000 )     -       -  
                                                 

Weighted average exercise price per share

  $ 7.90       -       -     $ 7.90       -       -  

 

 

2007 Share Incentive Plan

                                               
   

Beginning

   

Granted

   

Exercised

   

Canceled

   

Ending

         
   

Balance

   

During

   

During

   

During

   

Balance

         
   

Outstanding

   

Period

   

Period

   

Period

   

Outstanding

   

Exercisable

 
                                                 

Number of shares

    345,000       -       -       -       345,000       305,000  
                                                 

Weighted average exercise price per share

  $ 12.33       -       -       -     $ 12.33     $ 12.33  

 

 

2016 Share Incentive Plan

                                               
   

Beginning

   

Granted

   

Exercised

   

Canceled

   

Ending

         
   

Balance

   

During

   

During

   

During

   

Balance

         
   

Outstanding

   

Period

   

Period

   

Period

   

Outstanding

   

Exercisable

 
                                                 

Number of shares

    65,000       -       -       -       65,000       65,000  
                                                 

Weighted average exercise price per share

  $ 5.94       -       -       -     $ 5.94     $ 5.94  

 

 

The Company has a total of 410,000 of outstanding stock options and 370,000 exercisable under the three plans at March 31, 2021.

 

15

 

NOTE 9:         STOCK-BASED COMPENSATION EXPENSE (continued)

 

The following table summarizes information about the outstanding and exercisable options at March 31, 2021.

 

         

Options Outstanding

   

Options Exercisable

 
                 

Weighted

   

Weighted

                   

Weighted

         
                 

Average

   

Average

                   

Average

         

Exercise

   

Number

   

Remaining

   

Exercise

   

Intrinsic

   

Number

   

Exercise

   

Intrinsic

 

Price Range

   

Outstanding

   

Contractual

   

Price

   

Value

   

Exercisable

   

Price

   

Value

 
$4.00 - 7.00       45,000       .0     $ 5.00     $ 0       45,000     $ 5.00     $ 0  
$7.01 - 10.00       20,000       .0     $ 8.07     $ 0       20,000     $ 8.07     $ 0  
$10.01 - 12.00       220,000       .1     $ 10.81     $ 0       180,000     $ 11.05     $ 0  
$12.01 - 15.00       125,000       1.5     $ 15.00     $ 0       125,000     $ 15.00     $ 0  

 

No options were exercised for the three months ended March 31, 2021. As of March 31, 2021, there was $7,900 of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 1.00 years.

 

Restricted Stock Awards

 

The following table summarizes restricted stock awards for the three months ended March 31, 2021:

 

           

Weighted

 
           

Average Grant

 
   

Shares of

   

Date Fair

 
   

Restricted Stock

   

Value

 

Unvested outstanding at December 31, 2020

    0     $ 0  

Granted

    42,800     $ 4.65  

Vested

    0     $ 0  

Forfeited/Cancelled

    0     $ 0  

Unvested outstanding at March 31, 2021

    42,800     $ 4.65  

 

Restricted Stock Units

 

The following table summarizes restricted stock units for the three months ended March 31, 2021:

 

           

Weighted

 
   

Shares of

   

Average Grant

 
   

Restricted

   

Date Fair

 
   

Stock Units

   

Value

 

Unvested outstanding at December 31, 2020

    8,750     $ 5.00  

Granted

    2,333     $ 5.36  

Vested

    (5,583 )   $ 5.32  

Forfeited/Cancelled

    (- )   $ -  
                 

Unvested outstanding at March 31, 2021

    5,500     $ 4.83  

 

16

 

NOTE 9:         STOCK-BASED COMPENSATION EXPENSE (continued)

 

The total fair value of vested restricted stock units was $29,700 for the three months ended March 31, 2021.

 

The fair value of the outstanding restricted stock units will be recorded as stock compensation expense over the vesting period. As of March 31, 2021, there was $20,000 of total unrecognized compensation costs related to restricted stock units, which is expected to be recognized over a weighted-average period of 1.0 years.

 

 

NOTE 10:         INCOME TAXES

 

As of March 31, 2021 and December 31, 2020, the Company has provided a full valuation allowance against all of the net deferred tax assets. This was based on management’s assessment, including the last three years of operating losses, that it is more likely than not that the net deferred tax assets may not be realized in the future. On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted by the United States Congress. As a result of the enactment of the CARES Act, net operating losses (“NOL’s”) generated in 2018-2020 can now be carried back for five years and resulted in the Company recognizing approximately $1.5 million of a tax benefit, of which $.7 million is a receivable at March 31, 2021 and December 31, 2020. Management continues to evaluate for potential utilization of the Company’s deferred tax asset, which has been fully reserved for, on a quarterly basis, reviewing our economic models, including projections and timing of orders, and cost containment measures.

 

 

NOTE 11:         EARNINGS PER SHARE

 

Basic earnings per share is computed by dividing net earnings available to common shareholders (the numerator) by the weighted average number of common shares outstanding (the denominator) for the period presented. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common shares had been issued.

 

Stock options to purchase 410,000 shares of common stock were outstanding and 370,000 were exercisable at March 31, 2021. Stock options to purchase 417,000 shares were outstanding and 292,000 were exercisable at March 31, 2020. For the three months ended March 31, 2021, 410,000 stock options, and for the three months ended March 31, 2020, 417,000 stock options were not included in the computation of diluted earnings per share as their effect would have been anti-dilutive.

 

The dilutive potential common shares on options is calculated in accordance with the treasury stock method, which assumes that proceeds from the exercise of all options are used to repurchase common stock at market value. The number of shares remaining after the proceeds are exhausted represents the potential dilutive effect of the securities.

 

17

 

 

NOTE 12:          SEGMENT REPORTING

 

The Company operates through three (3) segments: CVD Equipment (“CVD”), Stainless Design Concepts (“SDC”) and CVD Materials (“Materials”). The CVD segment is utilized for chemical vapor deposition equipment manufacturing. SDC is the Company’s ultra-high purity manufacturing division in Saugerties, New York for gas control systems. The Materials segment was established to provide material coatings for aerospace, medical, electronic and other applications. The Company evaluates performance based on several factors, of which the primary financial measure is income or (loss) before taxes.

 

The Company’s corporate administration activities are reported in the Eliminations and Unallocated column. These activities primarily include intercompany profit, expenses related to certain corporate officers and support staff, expenses related to the Company’s Board of Directors, stock option expense for shares granted to corporate administration employees, certain consulting expenses, investor and shareholder relations activities, and all of the Company’s legal, auditing and professional fees, and interest expense.

 

NOTE 12:          SEGMENT REPORTING (continued)

 

Three Months Ended March 31,

(In thousands)

 

                           

Eliminations* and

         

2021

 

CVD

   

SDC

   

Materials

   

Unallocated

   

Consolidated

 

Assets

  $ 29,659     $ 6,116     $ 3,407     $ 24     $ 39,206  
                                         

Revenue

    2,006       827       629       (96 )     3,366  

Operating loss

    (575 )     (5 )     (110 )     (929 )     (1,619 )

Pretax (loss) income

    (590 )     (5 )     18       (929 )     (1,506 )
                                         

2020

                                       

Assets

  $ 36,699     $ 6,451     $ 5,653     $ (9 )   $ 48,794  
                                         

Revenue

    4,097       1,819       284       (164 )     6,036  

Operating income/(loss)

    592       603       (357 )     (730 )     108  

Pretax income/(loss)

    589       610       (341 )     (730 )     128  

 

 

*All elimination entries represent intersegment revenues eliminated in consolidation for external financial reporting.

 

18

 

 

NOTE 13:          SIGNIFICANT EVENTS- CORONAVIRUS (COVID-19)

 

The Company has been actively monitoring the coronavirus (COVID-19) outbreak and resulting pandemic and its impact on both the global economic and operating environment and specifically on its impact to the Company, its employees, its operations and its financial condition.  In March 2020, the World Health Organization recognized the COVID-19 outbreak as a pandemic based on the global spread of the disease, the severity of illnesses it causes and its effects on society. In response to the COVID-19 outbreak, the governments of many countries, states, cities and other geographic regions have taken preventative or protective actions, such as imposing restrictions on travel and business operations, including complete or partial government shutdowns of many schools and businesses, including our Company, and advising or requiring individuals to limit or forego their time outside of their homes. Accordingly, the COVID-19 outbreak has severely restricted the level of economic activity in many countries, including the United States, and continues to materially and adversely impact global economic activity.  In particular, the aerospace sector, for which the Company relies on a significant part of its business, has been faced with significant reductions to its business due to lack of air travel. The Company’s new order levels commencing in the first quarter of 2020, for the year ended December 31, 2020 and into the first quarter of 2021 have seen substantial reductions which have materially and adversely affected revenues commencing in our second quarter of 2020. While the financial results for the Company’s first quarter of 2020 reflected the initial impact of COVID-19, and the year ended December 31, 2020 and first quarter ended March 31, 2021 reflected a substantial adverse effect, the Company is unable to predict the extent of the impact the pandemic will have on its financial position and operating results for the remainder of 2021 due to numerous uncertainties, but the impact could be material during any future period affected either directly or indirectly by this pandemic.  The Company intends to continue to evaluate the various government sponsored plans and programs put in place in response to the COVID-19 pandemic and further plans to take advantage of any such government benefits reasonably available to it.  Moreover, the Company will continue to monitor developments in that area as new government initiatives are passed.

 

19

 

 

Item 2.   Managements Discussion and Analysis of Financial Condition and Results of Operations.

 

Except for historical information contained herein, this Managements Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. These statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements. Important assumptions and other factors that could cause actual results to differ materially from those in the forward-looking statements, include but are not limited to: competition in the Companys existing and potential future product lines of business; the Companys ability to obtain financing on acceptable terms if and when needed; uncertainty as to the Companys future profitability, uncertainty as to the future profitability of acquired businesses or product lines, uncertainty as to any future expansion of the Company and the effect of the novel coronavirus (COVID-19) on our business and operations, and those of our customers, suppliers and other third parties. Other factors and assumptions not identified above were also involved in the derivation of these forward-looking statements and the failure of such assumptions to be realized as well as other factors may also cause actual results to differ materially from those projected. The Company assumes no obligation to update these forward looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. Past results are no guaranty of future performance. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made. When used in this Report, the words believes, anticipates, expects, estimates, plans, intends, will and similar expressions are intended to identify forward-looking statements.

 

 

Coronavirus (COVID-19)

 

We have been actively monitoring the coronavirus ("COVID-19") outbreak and its impact globally.  Our primary focus to this point has been to ensure the health and safety of its employees.  To that end, we have adopted social distancing where appropriate, implemented travel restrictions, and has taken actions to ensure that locations and facilities are cleaned and sanitized regularly.  These are novel and challenging times and the magnitude of this crisis is requiring us to consider all options to promote the safety of employees, including, where appropriate, or where required to comply with foreign, national, state or local governmental authority recommendations, guidelines, and/or mandates, the temporary suspension of work at certain of our locations and production facilities to protect employees and curb the spread of the coronavirus.  All of these actions may adversely impact our operating results.  In particular, the aerospace sector, for which we rely on a significant part of our business, has been faced with significant reductions to its business due to lack of air travel. Due to the timing of the COVID-19 outbreak, our new order levels during the year ended December 31, 2020 and into the first quarter of 2021 have seen substantial reductions which have materially and adversely affected revenues commencing in our second quarter of 2020. While the financial results for the Company’s first quarter of 2020 reflected the initial impact of COVID-19, and the year ended December 31, 2020 and the quarter ended March 31 2021 reflected a substantial adverse effect, we are unable to predict the extent of the impact the pandemic will have on our financial position and operating results for the remainder of 2021 due to numerous uncertainties, but the impact could be material during any future period affected either directly or indirectly by this pandemic.  The longer-term impacts from the outbreak are highly uncertain and cannot be predicted.

 

20

 

Current Developments

 

Historically, we have derived substantially all of our revenues through our custom equipment business and our Stainless Design Concepts (“SDC”) gas management and chemical delivery control systems segment.  The marketing, sale and manufacture of our products, requires a lengthy sales cycle ranging from several months to over more than one year before we can complete production and delivery. Also, demand for our equipment and related consumable products and services may be volatile as a result of sudden changes in market conditions, competition and other factors. This can and has resulted in substantial volatility in our revenue stream. 

 

In order to address this sales volatility, we have attempted to diversify and expand our business into providing material products and services. This strategy included the development of our capabilities to provide materials coatings and surface treatments for targeted customer / market requirements (the “Material Business”). With this objective in mind, we acquired Tantaline in December 2016 and MesoScribe in October 2017. In order to facilitate these new lines of businesses, we also purchased a building to house both operating subsidiaries for $13,850,000. This 180,000 square foot building (the “555 Building”) was to house the Material Business in the United States and provide adequate space for the anticipated growth of these businesses. In addition, we also maintain a 130,000 square foot building (the “355 Building”), which houses the equipment products portion of our business as well as our corporate headquarters.

 

We have invested approximately $1.6 million, $2.7 million and $2.5 million during 2020, 2019 and 2018, respectively, in building improvements, machinery, and other expenses related primarily to the Materials Business. 

 

The projected growth of the Materials Business has not met expectations. Although we have made substantial investments in facilities, equipment and acquisitions in furtherance of our strategy, the foregoing has proven to be a significant drain on our finances and our liquidity. Since 2018 revenues for the Materials Business have been $1,700,000 in 2018, $1,600,000 in 2019 and $2,300,000 in 2020, with operating losses, exclusive of a $3.6 million impairment charge, recorded in all years for a total loss of $2.5 million. These cumulative results are due to operating losses from the Tantaline operations offset by operating profits of $.5 million from the MesoScribe operations. In the three months ended March 31, 2021 the Materials business had revenue of $.6 million and an operating loss of $.1 million. The operating loss was due to operating losses from the Tantaline operations, offset by operating profit of $.1 million from the MesoScribe operations.

 

21

 

Furthermore, our overall revenues have declined from $41.1 million in 2017 to $16.9 million in 2020. Cumulative operating losses, exclusive of a $3.6 million impairment charge, for the last three years (2018-2020) totaled ($14.5 million), which are comprised of 2018 ($5.3 million), 2019 ($5.0 million) and 2020 ($4.2 million). As a result of these continuing losses, and the investments in the Materials Business, our cash balances have declined from $21.7 million at December 31, 2016 to $7.7 million as of December 31, 2020 and $5.9 million at March 31, 2021, and liquidity has been strained. Contributing to and compounding this decline, is the negative effect the COVID-19 crisis has had in 2020 on the aerospace industry, which resulted from reduced travel and reduction of industry gas turbine engine sales. Aerospace sales in recent years have represented as much as 60% of our total revenue.

 

Our mortgage debt on the 355 Building and 555 Building, in the amount of $2.0 million and $9.2 million respectively, at March 31 2021, matures in March and December 2022, respectively.

 

In January 2021, our Board of Directors concluded that we needed a change in direction and new leadership to evaluate our business strategy and operations, and take timely actions to halt and reverse the declines of the past few years. As such, they appointed Emmanuel Lakios as President and Chief Executive Officer (previously our Vice-President- Sales and Marketing). We began an intensive analysis of our entire business and operations including the Materials Business. Based upon that analysis we believe our primary focus should be on the core equipment business and that the Materials Business strategy should be revised, with some of its current elements potentially minimized or ceased.  Based upon this analysis, we are forecasting continued losses and negative cash flow for our Tantaline product line and as a consequence, we have implemented plans to eliminate further investment in our Tantaline product line, which will result in the avoidance of approximately $1.5-$2.0 million in additional costs. In addition, we have recorded an impairment charge of $3.6 million during the fourth quarter and year ended December 31, 2020. Based upon certain decisions and actions currently being reviewed, there may be additional costs to be incurred, inclusive of employee related and lease termination costs estimated at approximately $400,000.

 

In order to increase our liquidity and to provide necessary working capital to support our on-going business and operations, we have decided to sell the 555 Building in February 2021. We have determined the 555 Building is not needed for present and future business operations. We have concluded that any remaining elements of the Materials Business can be consolidated into the 355 Building, which we believe can accommodate any needs for our growth for the foreseeable future. In April 2021, the Company completed the move of its Tantaline product line to the 355 Building, while the MesoScribe consolidation into the 355 Building has been initiated. All functions of the Tantaline product line have been consolidated into the Denmark office and the United States expenses related to Tantaline have ceased.

 

22

 

On March 29, 2021, the Company entered into an agreement with Steel K, LLC for the sale of its 555 Building. The purchase price is $24,360,000, and the closing of the sale is subject to the satisfaction or waiver of certain conditions to closing or contingencies. A portion of the sale proceeds would be used to satisfy the existing mortgage debt on the 555 Building in the approximate amount of $9.2 million at March 31, 2021, and for various costs related to the sale closing in an amount to be determined. The excess proceeds will be used for general working capital purposes. On or about May 23, 2021, the buyer may advise the Company of any requirement to extend the closing date up to 60 days thereafter.

 

Statement of Operations

 

   

Three Months Ended

 
   

March 31,

 
   

2021

   

2020

 
                 

Revenue

  $ 3,365,860     $ 6,036,360  
                 

Cost of revenue

    3,047,280       4,100,836  
                 

Gross profit

    318,580       1,935,524  
                 

Operating expenses

               

Research and development

    100,432       113,828  

Selling and shipping

    135,755       165,777  

General and administrative

    1,701,180       1,547,758  
                 

Total operating expenses

    1,937,367       1,827,363  
                 

Operating (loss) income

    (1,618,787 )     108,161  
                 

Other income (expense):

               

Interest income

    1,223       24,902  

Interest expense

    (107,221 )     (116,038 )

Other Income

    219,235       110,809  

Total other income, net

    113,237       19,673  
                 

(Loss) income before income tax

    (1,505,550 )     127,834  
                 

Income tax (benefit)

    -       (1,530,644 )
                 

Net (loss) income

  $ (1,505,550 )   $ 1,658,478  

 

23

 

Three Months Ended March 31, 2021 vs. March 31, 2020

 

Revenue

 

Our revenue for the three months ended March 31, 2021 was $3.4 million compared to $6.0 million for the three months ended March 31, 2020, a decrease of $2.6 million or 44.3%. This sales reduction is primarily attributed to the impacts of COVID-19 which significantly reduced the Company’s orders commencing in the first quarter of 2020, for the year ended December 31, 2020 and into the first quarter of 2021, which in turn dramatically decreased our revenues in the subsequent quarters. The decrease was primarily attributable to decreased revenue of $2.1 million from our CVD Equipment segment related to spare parts and equipment sales and $.8 million decrease in our SDC segment, offset, in part by, an increase of $.3 million in our CVD Materials segment.

 

The revenue contributed for the three months ended March 31, 2021 by the CVD Equipment segment of $2.0 million, which totaled 59.6% of our overall revenue, was (51.0%) or ($2.1 million) lower than the segment’s $4.1 million contribution made in the three months ended March 31, 2020, which totaled 67.9% of our overall revenue. This revenue decrease is the result of decreases of $1.9 million and $.2 million, from spare parts and equipment sales, respectively.

 

Revenue for our SDC segment was $.8 million in three months ended March 31, 2021 as compared to $1.6 million in three months ended March 31, 2020, a decrease of $.8 million, primarily the result of the timing of one large order completed in the three months ended March 31, 2020.

 

Revenues for our CVD Materials segment were $.6 million in the three months ended March 31, 2021 as compared to $.3 million for the three months ended March 31, 2020. This increase of $.3 million was the result of increased MesoScribe product revenue of $.2 million and Tantaline® related revenue of $.1 million.

 

 

Gross Profit

 

Gross profit for the three months ended March 31, 2021 amounted to $.3 million, with a gross profit margin of 9.5%, compared to a gross profit of $1.9 million and a gross profit margin of 32.1% for the three months ended March 31, 2020. The reduction in gross profit and gross profit margin, was primarily the result of the impact of $2.7 million in decreased sales as a result of the impact of COVID-19, and the impact of fixed costs and payroll to support higher sales levels, offset in part by reduced employee payroll and related costs commencing in the last two and a half weeks of the quarter ended March 31, 2020 as a result of the Coronavirus mandates imposed.

 

24

 

Research and Development, Selling and General and Administrative Expenses

 

Research and Development

 

Due to the technical development required on our custom orders, our research and development team and their expenses are charged to costs of goods sold when they are working directly on a customer project. When they are not working on a customer project, they work in our Application Laboratory and their costs are charged to research and development. For the three months ended March 31, 2021 and 2020, our research and development expenses totaled $100,000 and $114,000, respectively, a decrease of $14,000.

 

Selling

 

Selling expenses were $136,000 or 4.0% of the revenue for the three months ended March 31, 2021 as compared to $166,000 or 2.8% of the revenue for the three months ended March 31, 2020. The decrease was primarily the result of reduced employee and employee related costs, during the three months ended March 31, 2021.  

 

General and Administrative

 

General and administrative expenses for the three months ended March 31, 2021 were $1.7 million or 50.5% of revenue compared to $1.5 million or 25.6% of revenue for the three months ended March 31, 2020, an increase of $.2 million. As a result of the actions taken in January 2021 (noted above in the current developments) related to the change in direction and new leadership to evaluate our business strategy and operations, the increase in these expenses is primarily the result of increased legal costs of $235,000, of which $75,000 related to the preparation of the sale of the 555 Building, and the balance was related to general corporate governance, employee related matters and intellectual property, offset in part by lower employee payroll and related costs.

 

Operating loss

 

As a result of substantially lower sales and the resultant reduction in gross profit margins and increased general and administrative expenses, our operating loss was ($1.6 million) in the three months ended March 31 2021, compared with an operating income of $.1 million in the three months ended March 31, 2020.

 

Other income (expenses)

 

Other income (expenses) were $113,000 and $20,000 for the three months ended March 31, 2021 and 2020, respectively. Other income was $219,000 and $111,000 for the three months ended March 31, 2021 and 2020, respectively, from subleasing a portion of our CVD Materials facility. The decrease of $108,000 was the result of lower rent due to less occupancy in 2020. As a result of lower interest rates and lower cash balances, interest income decreased $24,000, to $1,000 for the three months ended March 31, 2021 as compared to $25,000 in 2020. In addition, Interest expense related to the Company’s mortgages decreased $9,000 to $107,000 in the three months ended March 31, 2021, as compared to $116,000 in 2020.

 

25

 

Income Taxes

 

For the three months ended March 31, 2021, there was no income tax expense as compared to an income tax benefit of $1.5 million for the three months ended March 31, 2020. On March 27, 2020, the CARES Act was enacted by the United States Congress. As a result of the enactment of the CARES Act, net operating losses (“NOL’s”) generated in 2018-2020 can now be carried back for five years and resulted in the Company recognizing approximately $1.5 million of a tax receivable. We continue to evaluate for potential utilization of our deferred tax asset, which has been fully reserved for, on a quarterly basis, reviewing our economic models, including projections and timing of orders, cost containment measures and other factors.

 

Net (loss) income

 

As a result of the foregoing factors, we reported a net loss of ($1.5 million), or ($0.23) per basic and diluted share, for the three months ended March 31, 2021, as compared to a net income of $1.7 million (which included the $1.5 million tax benefit as noted above), or $0.25 per basic and diluted share for the three months ended March 31, 2020.

 

Liquidity and Capital Resources

 

As of March 31, 2021, we had aggregate working capital of $12.3 million compared to aggregate working capital of $8.1 million at December 31, 2020. Our cash and cash equivalents at March 31, 2021 and December 31, 2020 were $5.9 million and $7.7 million, respectively.

 

Net cash used in operating activities was $1.6 million. This is the result of a net loss, adjusted for non-cash items, of $1.2 million, increased inventory of $.2 million, increased contract assets of $.5 million, and a $.4 million decrease accounts payable and other liabilities, offset in part by a decrease in accounts receivable of $.2 million due to timing of collections, decreased other current assets of $.2 million and increased accrued expenses of $.3 million

 

Long term debt decreased by $.2 million from principal payments on the mortgages related to our two facilities in Central Islip, NY.

 

We have a loan agreement with HSBC USA, N.A. (the “HSBC”) which is secured by a mortgage on our Central Islip headquarters at 355 South Technology Drive. The loan is payable in 120 consecutive equal monthly installments of $25,000 in principal plus interest and a final balloon payment upon maturity in March 2022. The balances as of March 31, 2021 and December 31, 2020 were approximately $2.0 million and $2.1 million respectively. Interest accrues on the loan, at our option, at the variable rate of LIBOR plus 1.75% or Prime less 0.5% (1.86% and 1.89% at March 31, 2021 and December 31, 2020, respectively).

 

26

 

On November 30, 2017, we purchased the premises located at 555 North Research Place, Central Islip, NY which is intended to house the CVD Materials segment. The purchase price of the land and the building was $13,850,000 exclusive of closing costs.

 

As part of the acquisition, our newly formed wholly-owned subsidiary, 555 N Research Corporation (the” Assignee”) and the Islip IDA, entered into a Fee and Leasehold Mortgage and Security Agreement (the ”Loan”) with HSBC in the amount of $10,387,500, which was used to finance a portion of the purchase price to acquire the premises located at 555 North Research Place, Central Islip, New York (the ”Premises”). The Loan was evidenced by the certain note, dated November 30, 2017 (the ”Note”), by and between Assignee and the Bank, and secured by a certain Fee and Leasehold Mortgage and Security Agreement, dated November 30, 2017 (the “Mortgage”), as well as a collateral Assignment of Leases and Rents (“Assignment of Leases”).

 

The Note is payable in 60 consecutive equal monthly installments of $62,481, including interest. The balances as of March 31, 2021 and December 31, 2020 were approximately $9.2 million and $9.3 million respectively. The Note bears interest for each Interest Period (as defined in the Note), at the fixed rate of 3.9148%. The maturity date for the Note is December 1, 2022. As a condition of the Bank making the Loan, we were required to guaranty Assignee’s obligations under the Loan. As of March 31, 2021, the full amount of this Note is recorded as Liabilities Held For Sale.

 

On August 5, 2019, we entered into a Mortgage Modification Agreement which replaced the former covenant with a Minimum Liquid Assets (“MLC”) covenant, and on October 22, 2020, we entered into a Second Mortgage Modification Agreement modifying certain MLC balances. We are in compliance with our financial covenant under the mortgage at March 31, 2021.

 

We have been actively monitoring the coronavirus ("COVID-19") outbreak and its impact globally.  Our primary focus to this point has been to ensure the health and safety of our employees.  To that end, we have adopted social distancing where appropriate, implemented travel restrictions, and have taken actions to ensure that locations and facilities are cleaned and sanitized regularly.  These are novel and challenging times and the magnitude of this crisis is requiring management to consider all options to promote the safety of our employees, including, where appropriate, or where required to comply with foreign, national, state or local governmental authority recommendations, guidelines, and/or mandates, the temporary suspension of work at certain of our locations and production facilities to protect employees and curb the spread of the Coronavirus.  All of these actions may adversely impact our operating results.  In particular, the aerospace sector, for which we rely on a significant part of our business, has been faced with significant reductions to its business due to lack of air travel. Due to the timing of the COVID-19 outbreak, our new order levels during the year ended December 31, 2020 and into the first quarter of 2021 have seen substantial reductions which have materially and adversely affected revenues commencing in our second quarter of 2020. While the financial results for the first quarter of 2020 reflected the initial impact of COVID-19, and year ended December 31, 2020 and the quarter ended March 31, 2021 reflected a substantial adverse effect, we are unable to predict the extent of the impact the pandemic will have on our financial position and operating results for the remainder of 2021 due to numerous uncertainties, but the impact could be material and adverse during any future period affected either directly or indirectly by this pandemic.  The longer-term impacts from the outbreak are highly uncertain and cannot be predicted.

 

27

 

On April 21, 2020, we entered into a loan agreement (the “Loan Agreement”) with HSBC Bank USA, National Association pursuant to which we were granted a loan in the principal amount of $2,415,970, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted by the United States Congress on March 27, 2020.

 

The PPP loan, the obligation of which is represented by a note issued by us, matures on April 21, 2022 and bears interest at a rate of 1% per annum. The note may be prepaid at any time prior to maturity with no prepayment penalties. Under the terms of the PPP, all or a portion of the Loan may be forgiven, based upon payments made in the first twenty-four weeks following receipt of the proceeds, related to payroll costs, continue group health care benefits, utilities and mortgage interest on other debt obligations incurred before February 15, 2020. We have filed an application for forgiveness in April 2021, and anticipates all or substantially all of the PPP loan to be forgiven.

 

As a result of the March 27, 2020 CARES Act enactment allowing the carryback of NOL’s five years, we recognized a $1.5 million tax benefit. We have collected $.8 million in the year ended December 31, 2020, and as of March 31, 2021 there remains a receivable in the amount of $.7 million.

 

Due to the timing of the COVID-19 outbreak, our new orders during the year ended December 31, 2020, and into the beginning of 2021 have decreased substantially which have resulted in substantial reductions in revenues resulting in operating losses commencing in our second quarter of 2020. The ongoing impact that COVID-19 has had on our business has made the conditions to operate very challenging. In particular, the aerospace sector, for which we rely on a significant part of our business, has been faced with significant reductions to its business due to lack of air travel. While we continue to monitor and take action to reduce our expenses, we have secured a $2.4 million loan under PPP and have recognized a $1.5 million tax receivable from the NOL 5 year carryback, of which $.7 million remains outstanding at March 31, 2021. In addition, we have decided to sell the 555 Building. The purchase price is $24,360,000, and the closing of the sale is subject to the satisfaction or waiver of certain conditions to closing or contingencies. A portion of the sale proceeds would be used to satisfy the existing mortgage debt on the 555 Building in the approximate amount of $9.2 million at March 31, 2021, and for various costs related to the sale closing in an amount to be determined. The excess proceeds will be used for general working capital purposes. On or about May 23, 2021, the buyer may advise the Company of any requirement to extend the closing date up to 60 days thereafter.

 

Based upon all of these factors, we believe that our cash and cash equivalent positions and cash flow from operations will be sufficient to meet our working capital and capital expenditure requirements for the next twelve months of the filing of this Form 10-Q. Should the current environment continue longer or worsen, we will continue to assess our operations and take actions anticipated to maintain our operating cash to support the working capital needs, as well as compliance with our loan covenant.

 

28

 

Off-Balance Sheet Arrangements.

 

We have no off-balance sheet arrangements at this time.

 

 

Item 3.                           Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4.                           Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 13d-15(e) under the Exchange Act of 1934, as amended, (the “Exchange Act”)). As required by Rule 13a-15(b) under the Exchange Act, our management, under the direction of our Chief Executive Officer and Chief Financial Officer, reviewed and performed an evaluation of the effectiveness of design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Report”).

 

Based on that review and evaluation, our Chief Executive Officer and Chief Financial Officer, along with others in our management, have determined that as of the end of the period covered by this Report on Form 10-Q the disclosure controls and procedures were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate to allow timely decisions regarding disclosures.

 

 

Changes in Internal Controls

 

There were no changes in our internal controls over financial reporting as defined in Rule 13a-15(f) or Rule 15d-15(f) under the Exchange Act that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the internal controls over financial reporting.

 

Limitations on the Effectiveness of Controls

 

We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

 

29

 

CVD EQUIPMENT CORPORATION

 

PART II

 

OTHER INFORMATION

 

 

Item 1.

Legal Proceedings.

 

None.

 

Item 1A.

Risk Factors.

 

None.

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3.

Defaults Upon Senior Securities.

 

None.

 

Item 4.

Mine Safety Disclosures.

 

Not applicable.         

 

Item 5.

Other Information.

None.

 

Item 6.

Exhibits

 

10.1

Agreement to Purchase and Sale, the building and real estate property located at 555 N Research Place, Central Islip, NY, dated March 29, 2021, by and between 555 N Research Corporation, a wholly-owned subsidiary of the Company, and Steel K, LLC. *

 

 

31.1*

Certification of Emmanuel Lakios, Chief Executive Officer, dated May 13, 2021

 

 

31.2*

Certification of Thomas McNeill, Chief Financial Officer, dated May 13, 2021

 

30

 

32.1*

Certification of Emmanuel Lakios, Chief Executive Officer, dated May 13, 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

32.2*

Certification of Thomas McNeill, Chief Financial Officer, dated May 13, 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

101.1**

XBRL Instance.

 

 

101.SCH**

XBRL Taxonomy Extension Schema.

 

 

101.CAL**

XBRL Taxonomy Extension Calculation.

 

 

101.DEF**

XBRL Taxonomy Extension Definition.

 

 

101.LAB**

XBRL Taxonomy Extension Labels.

 

 

101.PRE**

XBRL Taxonomy Extension Presentation.

________________

* Filed herewith.

 

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not to be filed or part of a registration statement of prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

 

31

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, this 13th day of May 2021.

 

  CVD EQUIPMENT CORPORATION
     
  By:

/s/ Emmanuel Lakios 

   

Emmanuel Lakios

   

Chief Executive Officer

   

(Principal Executive Officer)

     
  By:

/s/ Thomas McNeill

   

Thomas McNeill

   

Chief Financial Officer

   

(Principal Financial and

   

Accounting Officer)

 

32

 

 

EXHIBIT INDEX

 

10.1

Agreement to Purchase and Sale, the building and real estate property located at 555 N Research Place, Central Islip, NY, dated March 29, 2021, by and between 555 N Research Corporation, a wholly-owned subsidiary of the Company, and Steel K, LLC. *

 

 

31.1*

Certification of Emmanuel Lakios, Chief Executive Officer, dated May 13, 2021

 

 

31.2*

Certification of Thomas McNeill, Chief Financial Officer, dated May 13, 2021

 

 

32.1*

Certification of Emmanuel Lakios, Chief Executive Officer, dated May 13, 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

32.2*

Certification of Thomas McNeill, Chief Financial Officer, dated May 13, 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

101.1**

XBRL Instance.

 

 

101.SCH**

XBRL Taxonomy Extension Schema.

 

 

101.CAL**

XBRL Taxonomy Extension Calculation.

 

 

101.DEF**

XBRL Taxonomy Extension Definition.

 

 

101.LAB**

XBRL Taxonomy Extension Labels.

 

 

101.PRE**

XBRL Taxonomy Extension Presentation.

 

________________

* Filed herewith.

 

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not to be filed or part of a registration statement of prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

 

33

Exhibit 10.1

 

AGREEMENT OF PURCHASE AND SALE

 

THIS AGREEMENT OF PURCHASE AND SALE ("Agreement"), made as of March 29, 2021 (the "Effective Date"), by and between 555 N Research Corporation, a New York corporation, having an office at 355 South Technology Drive, Central Islip, NY 11722 ("Seller"), and Steel K, LLC, a Delaware limited liability company, having an office at c/o Steel Equities, 999 South Oyster Bay Road, Suite 200, Bethpage, New York 11714 (“Purchaser").

 

WHEREAS, Seller is the owner of certain real property located at 555 N. Research Place, Central Islip, NY 11722 (a/k/a District 0500; Section 164.00; Block 04.00; Lot 007.001), more fully described on Exhibit A attached hereto (the “Land”), and (ii) the buildings and other improvements (individually and collectively the “Improvements”) located on the Land (the Land and the Improvements located thereon are referred to herein as the “Property”); and

 

WHEREAS, Purchaser desires to purchase the Property from Seller, and Seller desires to sell the Property to Purchaser, in accordance with the terms, covenants and conditions of this Agreement.

 

W I T N E S S E T H :

 

NOW THEREFORE, in consideration of the promises made and exchanged herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Seller and Purchaser hereby covenant and agree as follows:

 

1.    Agreement to Sell and Purchase.

 

1.1.    Seller agrees to sell and convey and Purchaser agrees to purchase and acquire the Property subject to and in accordance with this Agreement.

 

1.2    For purposes of this Agreement, the term Property shall include the following:

 

(i)    all right, title and interest of Seller in and to (a) any land lying in the bed of any publicly-dedicated street, road or avenue, opened or proposed, in front of or adjoining the Land, to the center line thereof, (b) any award to be made in lieu thereof, and (c) any award hereafter made for damage to the Land by reason of the change of grade of any street. Seller shall execute and deliver to Purchaser at the Closing (as hereinafter defined), or thereafter, on demand all proper instruments for the conveyance of such title and the assignment and collection of any such award;

 

(ii)    all strips and gores, if any, abutting or adjoining the Land;

 

(iii)    all easements, bridges, rights of way, licenses, privileges, hereditaments and appurtenances, if any, as part of or inuring to the benefit of the Land; and

 

(iv)    all right, title and interest of Seller, if any, in and to the plans, specifications and all fixtures attached or appurtenant to or relating to the Improvements.

 

 

 

1.3    For purposes of this Agreement, “appurtenances” shall include all right, title and interest of Seller, if any, in and to (i) all licenses, permits, certificates of occupancy and other approvals issued by any state, federal or local authority relating to the use, maintenance or operation of the Property or the fixtures, machinery or equipment included in this sale to the extent that they may be transferred or assigned; (ii) all warranties or guaranties, if any, applicable to the Property, to the extent such warranties or guaranties are assignable; (iii) all tradenames, trademarks, servicemarks, logos, copyrights and goodwill relating to or used in connection with the operation of the Property, if any, and (iv) all air rights and development rights.

 

2.    Purchase Price and Payment.

 

2.1.    The purchase price (the "Purchase Price") payable to Seller for the Property is Twenty Four Million Three Hundred Sixty Thousand ($24,360,000.00) Dollars. The Net Purchase Price (as hereinafter defined) shall be paid to Seller at the Closing by wire transfer in Current Funds (as hereinafter defined) to the Escrow Agent. As used herein, the term “Net Purchase Price” shall mean the Purchase Price less the Downpayment (as hereinafter defined) and subject to such apportionments, adjustments and credits as are provided in Sections 6 and 12 hereof.

 

2.2.    The Purchase Price is payable as follows:

 

2.2.1.    Purchaser shall pay the sum of One Million Two Hundred Eighteen Thousand ($1,218,000.00) Dollars (the “Downpayment”), not later than one (1) business day after the date hereof, by wire transfer of immediately available federal funds (“Current Funds”), to Ruskin Moscou Faltischek, P.C., as escrow agent (“Escrow Agent”) to the following account:

 

IMAGE.JPG

 

2.2.2.    The balance of the Purchase Price in the amount of Twenty Three Million One Hundred Forty Two Thousand ($23,142,000.00) Dollars, subject to the prorations, credits and payments specified in this Agreement, shall be paid at the Closing (as hereinafter defined), by Current Funds to Seller or Seller’s order.

 

2

 

2.3.    The Downpayment shall be held in escrow by Escrow Agent and disbursed in accordance with the terms and conditions of this Agreement. If Purchaser fails to deposit the Downpayment with the Escrow Agent as herein provided, Seller may, at its option, terminate this Agreement, in which event neither Seller nor Purchaser shall have any further rights, duties or obligations hereunder except for provisions of this Agreement which expressly survive the termination of this Agreement. Seller may direct the Escrow Agent to deposit the Downpayment in an interest bearing money market escrow account and any interest earned on the Downpayment shall be deemed to be part of the Downpayment and shall be paid together with the principal portion of the Downpayment, it being understood and agreed that any interest earned on the Downpayment shall not be credited to the Purchase Price upon the Closing and shall, upon the Closing, be and remain the property of Seller. The Deposit shall be held subject to the terms of Article 24 of this Agreement. The Downpayment shall be completely non-refundable to Purchaser except as otherwise expressly provided in this Agreement.

 

2.4.    (a) Purchaser expressly agrees and acknowledges that Purchaser's obligations hereunder are not in any way conditioned upon or subject to Purchaser obtaining financing of any type or nature whatsoever, whether by way of debt, equity investment, or otherwise (“Financing”) to consummate the transaction contemplated hereby. While this Agreement is not contingent upon Purchaser obtaining Financing, Seller shall, at no cost, expense or liability to Seller, reasonably cooperate with Purchaser’s Institutional Lender (as identified in Real Property Law Section 274-a) providing Financing at Closing, provided, (i) such Financing shall not modify or alter this Agreement, (ii) Seller shall not be required to incur any expense or make any repairs or alterations in connection with such Financing, (iii) Seller shall not be required to obtain or provide additional agreements or other documents in connection with such Financing, (iv) such Financing shall not delay the Closing, and (v) Purchaser’s failure to obtain such Financing shall not relieve Purchaser from any obligations under this Agreement.

 

(b)          At the request of Purchaser, Seller agrees to request that the holder (the “Existing Lender”) of the existing mortgage(s) encumbering the Property (the “Existing Mortgage”), assign the lien of the Existing Mortgage to Purchaser’s lender at the Closing; provided, however, it being expressly understood that the assignment by the Existing Lender of the Existing Mortgage to Purchaser’s lender shall not be a condition precedent to the obligation of Purchaser to Close hereunder, nor shall the refusal or inability of the Existing Lender to assign the Existing Mortgage give Purchaser a reason or a right not to Close hereunder. Purchaser further expressly acknowledges and agrees that (i) no such assignment or request for an assignment shall delay the Closing, and (ii) this Agreement does not contain any financing (or mortgage) contingency, either express or implied.  Purchaser shall be responsible for and shall pay all fees charged by the Existing Lender and the IDA for such assignment, including, without limitation, the legal fees and expenses of the Existing Lender’s attorneys, the IDA’s attorney, as well as all recording and filing costs in connection with such assignment.  Purchaser acknowledges that Purchaser has been advised that the IDA may not permit the Existing Mortgage to be assigned. If the Existing Mortgage is assigned to Purchaser’s lender at Closing, the Existing Mortgage (as assigned and amended, modified and/or consolidated) shall be a Permitted Exception under this Agreement and Seller shall be released from all further liability thereunder. The obligations of Purchaser pursuant to this Section 27.10 shall survive the Closing

 

3

 

2.5.    Purchaser and Seller agree that the entire Purchase Price shall be allocated to the Property. The value of any personal property that is included in the transaction contemplated by this Agreement is de minimis, and no part of the Purchase Price is allocable thereto. The parties shall execute all forms required to be filed for tax purposes with any taxing authority in a manner consistent with such allocation.

 

3.    Exceptions to Title; Title Matters.

 

3.1.    Seller shall transfer and Purchaser shall accept fee simple title to the Property in accordance with the terms of this Agreement, subject to the following matters (collectively, the "Permitted Exceptions"):

 

3.1.1.    All presently existing and future liens for unpaid real estate taxes, PILOT payments, water charges and sewer rents as of the Closing Date, subject to adjustment as provided below.

 

3.1.2.    All present and future zoning, building, environmental and other laws, ordinances, codes, rules, restrictions and regulations of all governmental authorities having jurisdiction with respect to the Property, including, without limitation, landmark designations and all zoning variances and special exceptions, if any (collectively, "Laws and Regulations").

 

3.1.3.    All recorded covenants, restrictions, reservations and easements, and all agreements for the erection and/or maintenance of water, gas, steam, electric, telephone, sewer or other utility pipelines, poles, wires, conduits or other like facilities, and appurtenances thereto, over, across and under the Property (collectively, "Rights") provided that the same are not violated by the Improvements and the present use of the Property and provided further that if any such matters contain a reversion clause, the Title Company insures that any future violation shall not result in a reversion of title.

 

3.1.4.    Any state of facts shown in the survey prepared by Schnepf & Murrell, P.C. dated November 6, 2017, last updated May 7, 2018, and any additional facts that would be disclosed by a survey of the Property, provided such state additional facts do not render title uninsurable in accordance with this Agreement without additional premium.

 

3.1.5.    Consents presently existing of record by the Seller or any former owner of the Property for the erection of any structure or structures on, under or above any street or streets on which the Property may abut.

 

3.1.6.    Possible minor (less than one (1) foot) encroachments and/or projections of stoop areas, roof cornices, window trims, vent pipes, cellar doors, steps, columns and column bases, flue pipes, signs, piers, lintels, window sills, fire escapes, satellite dishes, protective netting, sidewalk sheds, ledges, fences, coping walls (including retaining walls and yard walls), walkways, landscaping parking areas, curbing, sprinklers, driveways, fences, light poles, signs, air conditioners and the like, if any, on, under or above any street or highway, the Property or any adjoining property, provided that the Title Company omits any “out of possession” exception relating thereto.

 

3.1.7.    Minor variations between tax lot lines and lines of record title.

 

4

 

3.1.8.    Standard conditions, exclusions and exceptions to title contained in the ALTA owner’s form of title policy approved in New York.

 

3.1.9.    Any financing statements, chattel mortgages, encumbrances or mechanics' or other liens entered into by, or arising from, any financing statements filed more than five (5) years prior to the Closing and any financing statements, chattel mortgages, encumbrances or mechanics' or other liens filed against property no longer on the Property, provided that the Title Company shall omit or insure over such exceptions in Purchaser's title insurance policy.

 

3.1.10.    The following leases and the rights of tenants to possession of portions of the Property in accordance with the leases:

 

(a)      that certain lease dated November 23, 2020 (the “Eastside Lease”) by and between the Seller, as landlord, and Elm Freight Handlers Inc., D/B/A Elm Global Logistics, as tenant; and

 

(b)    that certain lease dated May 31, 2019, as extended by notice of the exercise of the second lease option from tenant Seller dated November 19, 2020 (the “Westside Lease”), by and between Seller, as landlord, and Elm Freight Handlers Inc., D/B/A Elm Global Logistics, as tenant.

 

The Eastside Lease and the Westside Lease are collectively referred to as the “Leases”.

 

3.1.11.    Rights, if any, relating to construction, maintenance and operation of public utility lines, wires, poles, cables, pipes, distribution boxes and other equipment and installations on, over and under the Property.

 

3.1.12.    Real estate taxes, PILOT payments, water charges and sewer rents, if any, not yet due and payable and subject to apportionment as provided herein;

 

3.1.13.    Covenants and Restrictions as recorded in Liber 11461 Page 401 and Liber 11556 Page 48 in the Suffolk County Clerk’s Office.

 

3.1.14.    Covenants and Restrictions as recorded in Liber 11774 Page 188 and Liber 11774 Page 189 in the Suffolk County Clerk’s Office.

 

3.1.15.    Telephone Easement recorded as Liber 11566 Page 517 in the Suffolk County Clerk’s Office.

 

3.1.16.    Right of Way as recited in Liber 11844 Page 879 in the Suffolk County Clerk’s Office.

 

3.1.17.    Sewer Line Easement as recorded in Liber 8360 Page 280 in the Suffolk County Clerk’s Office.

 

5

 

3.1.18.    Sewer Easement as recorded in Liber 11191 Page 530 and Liber 11185 Page 585 in the Suffolk County Clerk’s Office.

 

3.1.19.    Grant of Easement and Option to Purchaser Agreement dated July 24, 1997, recorded August 6, 1997 recorded in Liber 11844 Page 878 in the Suffolk County Clerk’s Office.

 

3.2.    Purchaser agrees to order a title commitment for the Property (the “Title Report”) from Stewart Title Insurance Company (the “Title Company”), and Purchaser shall direct the Title Company to furnish to Seller’s attorney simultaneously with the transmittal to Purchaser’s attorney a copy of the Title Report and all supplements (each a “Supplement”) thereto. If Purchaser shall fail to notify Seller’s attorney on or before the expiration of the Environmental Diligence Period (or on or prior to the Closing Date with respect to matters first raised by the Title Company in a continuation report first delivered at Closing), of the existence of any defect, lien or encumbrance (each a “Title Defect” and collectively, the “Title Defects”) other than a Permitted Exception, Purchaser shall be deemed to have waived its right to object to such Title Defects. Such notice shall include a description of the Title Defects objected to by Purchaser. For purposes of this Agreement, delivery of the Title Report to Seller’s attorney shall be deemed to satisfy the notice requirement above.

 

3.3.    Notwithstanding any provision to the contrary contained in this Agreement, with respect to any matter which the Title Company may raise as an exception to title in the Title Report, if First American Title Insurance Company, Chicago Title Insurance Company, Fidelity National Title Insurance Company or Commonwealth Land Title Insurance Company would be willing to, as applicable, (i) insure against collection or enforcement of same out of the Property, or (ii) insure that no prohibition of the present use of the Property will result therefrom, in each instance, without additional charge to Purchaser, then same shall constitute a Permitted Exception hereunder, even if the Title Company named in Section 3.2 is not willing to so insure. For purposes of this Agreement, the term “Title Company” shall include any title company described in the preceding sentence that is willing to so insure title.

 

3.4.    (a) If, at the Closing, Seller fails or is unable to convey to Purchaser title to the Property subject to and in accordance with the provisions of this Agreement, Seller shall be entitled, upon written notice delivered by email or fax to Purchaser’s attorney, to reasonable adjournments of the Closing Date to enable Seller to convey such title, provided such adjournments shall not exceed sixty (60) days in the aggregate. No action taken by Seller shall be an admission that Seller is unable to convey title to the Property in accordance with this Agreement. Except for Seller’s willful default, if Seller does not so elect to adjourn the Closing, or if Seller has adjourned the Closing Date for an additional period and following all of Seller’s adjournments, Seller is unable to convey title subject to and in accordance with the provisions of this Agreement, Purchaser may terminate this Agreement by written notice delivered on or promptly after the date scheduled for the Closing, as last adjourned by Seller, in which event the Escrow Agent shall repay to Purchaser the Downpayment (as hereinafter defined) and reimburse Purchaser for reasonable title search fees (without insurance) and reasonable survey costs, subject to Section 24 hereof, and this Agreement shall thereupon be deemed terminated and of no further effect, and neither party hereto shall have any obligations of any nature to the other hereunder or by reason hereof, except that the provisions of Sections 5.8, 13, 24, 25 and 26 hereof shall survive such termination. Except as otherwise expressly provided in this Agreement, Seller shall not be required to take or bring any action or proceeding or any other steps to remove any Title Defect in or objection to title or to fulfill any condition precedent to Purchaser's obligations under this Agreement or to expend any moneys therefor, nor shall Purchaser have any right of action against Seller therefor, at law or in equity.

 

6

 

(b)          Notwithstanding the foregoing provisions of this Section 3, Seller shall satisfy and discharge (or cause the Title Company to insure over) all Voluntary Liens (as hereinafter defined) on or prior to the Closing Date. The term “Voluntary Liens” shall mean liens and other encumbrances which Seller has knowingly and intentionally placed on the Property, or any part thereof, or with respect to which Seller has taken an affirmative action that directly results in the placement of same against the Property, or any part thereof, including, without limitation, any and all (i) mechanics’ liens and/or materials relating to work performed or alleged to be performed at the Property; (ii) recapture of benefit payments or other penalties or charges, if any, owing to the Town of Islip Industrial Development Agency as a result of the sale of the Property and/or termination of the IDA Lease; (iii) mortgages recorded for money borrowed by Seller; and (iv) any encumbrance of title created by Seller following the Effective Date.

 

3.5.    If at the Closing there are any liens or encumbrances on the Property which are not Permitted Exceptions and which Seller is obligated by this Agreement or elects to pay and discharge, Seller may use any cash portion of the Purchase Price for the Property to satisfy the same. Purchaser, if request is made within a reasonable time prior to the Closing, agrees to provide at the Closing separate certified or official bank checks as requested, aggregating the amount of the cash balance of the Purchase Price, to facilitate the satisfaction of any such liens or encumbrances. Any judgments, mortgage liens, other encumbrances, encroachments or any other defects may be, and shall be deemed satisfied upon Seller depositing with the Title Company funds sufficient to satisfy same in full, together with the cost of recording the satisfaction instrument(s) and/or causing a Title Company to insure title to the Property.

 

3.6.    Notwithstanding anything in Section 3.4 above to the contrary, Purchaser may at any time Close title to the Property irrespective of the condition of the Seller’s title to the Property as it exists on the Closing Date without reduction of the Purchase Price or any credit or allowance on account thereof or any claim against Seller. The acceptance of the Deed by Purchaser shall be deemed to be full performance of, and discharge of, every agreement and obligation on Seller's part to be performed under this Agreement, except for such matters which are expressly stated in this Agreement to survive the Closing, to the limit of such survival.

 

3.7.    The amount of any unpaid taxes, assessments, PILOT payments, water charges and sewer rents affecting the Property on the Closing Date which the Seller is obligated to pay and discharge, with interest and penalties if any, may at the option of Seller be paid by the Seller, or by Purchaser out of the balance of the Purchase Price, if official bills therefor with interest and penalties thereon figured to said date are furnished to or obtained by the Title Company at the Closing for payment thereof and the Title Company is willing to insure against collection or enforcement of same out of the Property.

 

7

 

3.8.    If the Property shall, at the time of the Closing, be subject to any liens for transfer, inheritance, estate, franchise or other similar taxes, judgments or any encumbrances or other Title Defects which would be grounds for Purchaser to terminate this Agreement, the same shall not be deemed an objection to title provided that, at the time of the Closing, either (a) the Seller delivers to the Title Company at the Closing the amount required to satisfy the same and delivers to Purchaser and/or the Title Company at the Closing instruments in recordable form (and otherwise in form reasonably satisfactory to the Title Company in order to omit the same as an exception to its title policy) sufficient to satisfy and discharge of record such liens and encumbrances together with the cost of recording or filing such instruments, or (b) the Title Company will otherwise issue or bind itself to issue a policy which will insure against collection thereof from or enforcement thereof against such Property.

 

3.9.    If Property does not have a certificates of occupancy or completion, or, if there are any variances between such certificates and the actual state or uses of the Property, the same shall not be deemed to be an objection to title.

 

3.10.     Seller will comply with all notes or notices or violations of law or municipal ordinances, orders or requirements noted in or issued by any federal, State, County or other local governmental agency or department having jurisdiction as to lands, housing, buildings, fire, health and labor conditions (collectively the “Violations”) affecting the Property on the Effective Date. The Property shall be transferred free of the Violations at Closing. Seller shall pay all fines and penalties assessed or imposed for such Violations and Seller shall pay any fines and penalties assessed or imposed for any Violations on the Closing Date. This Section 3.10 shall survive Closing.

 

4.          Closing.

 

4.1.    The closing of title in accordance with this Agreement (the “Closing”, the actual date of the Closing being herein referred to as the “Closing Date”) shall take place on the date which is thirty (30) days after the expiration of the Environmental Diligence Period. TIME SHALL BE OF THE ESSENCE with respect to all of Seller’s and Purchaser's obligations under this Agreement, subject however, to Seller’s right to adjourn the Closing in accordance with this Agreement and Purchaser shall have the one-time right to extend the Closing Date for a period of sixty (60) days, by delivering written notice to Seller of such extension not later than five (5) days prior to the scheduled Closing Date and delivering to the Escrow Agent an additional One Million Two Hundred Eighteen Thousand ($1,218,000.00) Dollars (the “Extension Downpayment”) within one (1) business day after delivery of such notice. For purposes of this Agreement, the Downpayment shall include the Extension Downpayment.

 

4.2.    The Closing shall occur at the offices of Title Company or at such other location as may be mutually agreed upon by Seller and Purchaser. The parties intend that the Closing will not be attended in person by representatives of the parties. Rather, the Closing shall occur by; (a) delivery of the Closing Documents by the Seller and Purchaser to the Title Company in escrow on or before the scheduled date of Closing, and (b) Purchaser shall deposit funds in the amount of the Net Purchase Price, plus or minus applicable prorations, with the Title Company in a closing escrow account with a bank satisfactory to both Purchaser and Seller. Upon satisfaction or completion of all closing conditions and deliveries, the parties shall direct Title Company to immediately record and deliver the Closing Documents to the appropriate parties and make disbursements according to the closing statements executed by Seller and Purchaser.

 

8

 

5.          Environmental Diligence Period; As Is.

 

5.1.    During the period (the “Environmental Diligence Period”) commencing on the Effective Date and ending 5:00 PM on the thirtieth (30th) day following the Effective Date, Purchaser shall have the right to have a Phase I environmental site assessment conducted at the Property by a duly licensed environmental consultant, during normal business hours on reasonable notice to Seller. Seller has heretofore provided Purchaser with a copy of the phase I Environmental Site Assessment prepared by The Vertex Companies, Inc. dated October 30, 2017 (the “Vertex Phase I”). Purchaser acknowledges that Purchaser has reviewed the Vertex Phase I and is satisfied with the environmental condition of the Property as described in the Vertex Phase I. If Purchaser’s Phase I investigation discloses the existence of new recognized environmental conditions that are not in the Vertex Phase I (“New RECs”), Purchaser shall have the right to investigate such New REC’s in a Phase II investigation. Purchaser acknowledges that the Vertex Phase I has been provided by Seller as a courtesy and Purchaser is relying exclusively upon its own independent investigation and evaluation of every aspect of the Property and not on any materials or information furnished by Seller.

 

5.1.1.     Any access to the Property required by Purchaser in connection with the inspection of the Property contemplated hereunder (i) must be upon written notice to Seller (which notice may be delivered electronically to Seller’s attorney at: bweinstock@rmfpc.com with a copy to Seller at: tmcneill@cvdequipment.com) and during reasonable business hours, and (ii) at all times Purchaser and its representatives may be accompanied by a representative of Seller when at the Property. Purchaser shall repair all damage caused to the Property arising or resulting from such inspection.

 

5.1.2.    Purchaser shall not, and shall not permit its employees, consultants, engineers, contractors, representatives and agents to, conduct any soil test or sampling, boring, digging or any other invasive investigation of the Property or the Improvements, including, without limitation a Phase II environmental investigation (collectively, “Testing”) without the prior written consent of Seller, which consent shall not be unreasonably withheld, conditioned or delayed. If Seller consents thereto, Purchaser shall (a) furnish to Seller property damage and commercial general liability insurance policies with combined single limit coverage amounts not less than $2,000,000.00 per event, irrespective of the number of events in any year, prior to commencing any such Testing and shall, upon completion thereof, restore promptly, at Purchaser’s own cost and expense, the Property to its condition existing prior to such Testing, and (b) at all times be accompanied by a representative of Seller when at the Property.

 

9

 

5.1.3.    Purchaser shall indemnify, defend and hold Seller harmless from and against all loss, liability, cost and expense (including, without limitation, reasonable attorney’s fees and disbursements) arising out of or in connection with the acts of Purchaser, its representatives, partners, shareholders, agents, employees, licensees, invitees, contractors and consultants in connection with any inspection and/or Testing conducted at the Property. This indemnity shall survive Closing and termination of this Agreement.

 

5.1.4.    Purchaser shall promptly provide Seller with complete copies of all tests, reports, laboratory results and other information obtained by Purchaser from its consultants, engineers and others concerning the inspection, Testing and the environmental condition of the Property.

 

5.2.    If Purchaser’s Testing determines that there has been a release of “Hazardous Materials” (hereinafter defined) on the Property that requires remediation (“Remediation”) in accordance with applicable “Environmental Laws” (hereinafter defined) Purchaser shall cause the Remediation to be performed following the Closing and Seller shall reimburse Purchaser for up to the first One Hundred Thousand ($100,000.00) Dollars of the costs of the Remediation (the “Remediation Costs”), and Purchaser shall pay the next Fifty Thousand ($50,000.00) Dollars of the Remediation Costs. If Seller receives notice from the Purchaser before the expiration of the Environmental Diligence Period that the reasonably estimated Remediation Costs are reasonably expected to exceed One Hundred Fifty Thousand ($150,000.00) Dollars, then Purchaser may terminate this Agreement by giving a Termination Notice in accordance with Section 5.5, provided however, that Seller may nullify Purchaser’s Termination Notice by giving Purchaser notice within ten (10) days following Seller’s receipt of the Termination Notice, in which case Seller shall pay all Remediation Costs in excess of One Hundred Fifty Thousand ($150,000.00) Dollars.

 

5.3.    Purchaser shall use all information concerning the presence of Hazardous Materials affecting the Property (“Confidential Information”) only for purposes of evaluating the Property in connection with its purchase thereof in accordance with the terms of this Agreement. Purchaser further agrees that prior to the Closing, Purchaser shall not disclose the Confidential Information to anyone other than Purchaser and to the Transaction Parties (as hereafter defined in Section 25) and who (i) have a need to review the Confidential Information for the purpose of advising Purchaser on the suitability of the Property for purchase, (ii) have been informed in writing of the confidential nature of such information and (iii) have agreed to receive and use all Confidential Information in accordance with the provisions of this Section 5.3. Notwithstanding the foregoing, to the extent that Purchaser is required to disclose the Confidential Information by Laws or Regulations or pursuant to a subpoena, court order or other legal proceeding, Purchaser shall promptly notify Seller of such legally required disclosure. Purchaser shall cooperate with Seller’s counsel in any appeal or challenge to such disclosure. If no protective order or similar relief is obtained, Purchaser shall (i) disclose only that portion of the Confidential Information that it is legally obligated to disclose, (ii) exercise reasonable efforts to obtain reliable assurances that the disclosed information will be kept confidential, and (iii)  provide Seller with a copy of the information to be disclosed before the same is disclosed to any third party.

 

5.4.    If this Agreement is terminated, (i) Purchaser shall use commercially reasonable efforts to (i) destroy all Confidential Information which is in tangible form, including any copies Purchaser has made and other embodiments thereof, and (ii)  destroy all extracts, summaries and compilations thereof and references thereto which are in Purchaser’s notes, documents, databases or other records (whether prepared by Purchaser or by Seller), and in either case Purchaser will certify in writing to Seller that it has done so.

 

10

 

5.5.    A notice of termination (“Termination Notice”) that may be given pursuant to Section 5, shall be in writing and given to Seller (which notice may be delivered electronically to Seller’s attorney at: bweinstock@rmfpc.com with a copy to Seller at: tmcneill@cvdequipment.com) and must be received by Seller on or before the expiration of the Environmental Diligence Period. If a Termination Notice is timely received by Seller’s attorney, this Agreement shall thereupon terminate and shall be of no further force or effect, except for those matters that expressly survive the termination of this Agreement, the Escrow Agent shall return the Downpayment to Purchaser in accordance with Section 24 hereof. TIME SHALL BE OF THE ESSENCE WITH RESPECT TO PURCHASER’S ACTIONS PURSUANT TO THIS SECTION 5. If Purchaser’s Termination Notice is not received by Seller’s attorney prior to the expiration of the Environmental Diligence Period, Purchaser shall be deemed to have irrevocably waived the right to cancel this Agreement as provided in this Section 5.

 

5.6.    Purchaser represents that Purchaser is an experienced and sophisticated purchaser of commercial and industrial real estate projects such as the Property and that prior to the Effective Date, it has conducted such investigations, examinations, inspections and analyses of the Property as Purchaser deems appropriate, except as otherwise set forth herein concerning a Phase I investigation and Testing.

 

11

 

5.7.    Except as otherwise provided in this Agreement, Purchaser acknowledges and agrees that it is purchasing the Property in “AS IS, WHERE IS AND WITH ALL FAULTS, LIABILITIES, AND DEFECTS, LATENT OR OTHERWISE, KNOWN OR UNKNOWN” condition, based on its condition as of the Effective Date, reasonable wear and tear (loss by casualty or condemnation excepted), with no right of set-off or reduction in the Purchase Price, and that, except for the Seller’s representations expressly set forth in this Agreement, such sale shall be without representation or warranty of any kind, express or implied, all of which are renounced by Seller and waived by Purchaser. Purchaser specifically acknowledges that, except for the Seller’s representations expressly set forth in this Agreement, Purchaser is not relying on any representations or warranties of any kind whatsoever, express or implied, from Seller, any other party, broker or other agent representing or purporting to represent Seller as to any matters concerning the Property including: (i) the income from or value of the Property; (ii) any income to be derived from the Property; (iii) the suitability of the Property for any and all activities and uses which Purchaser may conduct thereon, including the possibilities for further development of the Property or construction thereon; (iv) the habitability, merchantability, marketability, profitability or fitness for a particular purpose of the Property or any Improvements thereon; (v) the manner, quality, state of repair or lack of repair of the Property (including the roof, foundation, HVAC systems or any other component of the Property or any improvements thereon); (vi) the nature, quality or condition of the Property, including with respect to water conditions, soil, geological or geotechnical condition (including soil expansiveness, corrosivity, or stability, or seismic, hydrological, geological and topographical conditions and configurations, including, without limitation, any opinions or conclusions of any soils engineer(s) retained to perform geotechnical and/or soils studies or to oversee any soils engineering aspects of developing the Property); (vii) the compliance of or by Seller, the Property, or its operation with any Laws and Regulations; (viii) the manner or quality of the construction or materials incorporated into the Property; (ix) compliance with Environmental Laws or land use laws, rules, regulations, orders, codes or requirements, including the Americans with Disabilities Act of 1990; (x) the presence or absence of radon gas, methane gas, asbestos any other Hazardous Materials at, on, under, or adjacent to the Property; (xi) the conformity of any improvements to any plans or specifications, including any plans and specifications that may have been or may be provided to Purchaser; (xii) the conformity of the Property to past, current or future applicable zoning or building requirements; (xiii) deficiency of any undershoring; (xiv) deficiency of any drainage; (xv) the fact that all or a portion of the Property may be located on or near an earthquake fault line or in or near an earthquake or seismic hazard zone; (xvi) the existence of vested land use, zoning or building entitlements affecting the Property; (xvii) water rights or the availability of or access to water; (xviii) the presence or suitability of any utilities or availability thereof; (xix) the current or future real estate tax liabilities, assessments or valuations of the Property, (xx) the potential qualification of the Property for any and all benefits conferred by Federal, state or municipal laws, whether for subsidies, special real estate tax treatment, insurance, mortgages, or any other benefits, whether similar or dissimilar to those enumerated, (xxi) the present and future condition and operating state of any and all machinery or equipment on the Property and the present or future structural and physical condition of the Improvements or their suitability for rehabilitation or renovation, (xxii) the ownership or state of title of any personal property on the Property, (xxiii) the completeness or accuracy of any information provided to Purchaser by the Seller or the Seller Related Parties (hereinafter defined); (xxiv) any matters relating to the Leases or the tenants; (xxv) any knowledge that the Seller may have relating to the Property that it has, or has not, shared with Purchaser; or (xxvi) any other matter relating to the Property, the Leases or the tenants or to the development, construction, operation, or sale of the Property. Purchaser further acknowledges and agrees that Seller is not under any duty to make any affirmative disclosures or inquiry regarding any matter which may or may not be known to Seller, and Purchaser, for itself and for its successors and assigns, hereby expressly waives and releases Seller from any such duty that otherwise might exist. Purchaser is and will be relying strictly and solely upon its own inspections and examinations and the advice and counsel of its own consultants, agents, legal counsel and officers and Purchaser is fully satisfied that the Purchase Price is fair and adequate consideration for the Property.

 

12

 

5.8.    Seller disclaims all warranties of any kind or nature whatsoever (including warranties of habitability and fitness for particular purposes), whether expressed or implied, with respect to the presence of Hazardous Materials on, above or beneath the Land (or any parcel in proximity thereto) or in any water on or under the Property. The Closing shall be deemed to constitute an express waiver of Purchaser's right to cause Seller to be joined in any action brought under any Environmental Laws. The term "Hazardous Materials" means (a) those substances included within the definitions of any one or more of the terms "hazardous materials", "hazardous wastes", "hazardous substances", "industrial wastes", and "toxic pollutants", as such terms are defined under the Environmental Laws, or any of them, (b) petroleum and petroleum products, including, without limitation, crude oil and any fractions thereof; (c) natural gas, synthetic gas and any mixtures thereof, (d) asbestos and or any material which contains any hydrated mineral silicate, including, without limitation, chrysotile, amosite, crocidolite, tremolite, anthophylite and/or actinolite, whether friable or non-friable, (e) polychlorinated biphenyl ("PCBs") or PCB-containing materials or fluids, (f) radon, (g) any other hazardous or radioactive substance, material, pollutant, contaminant or waste, and (h) any other substance with respect to which any Environmental Law or governmental authority requires environmental investigation, monitoring or remediation. The term "Environmental Laws" means all federal, state and local laws, statutes, ordinances and regulations, now or hereafter in effect, in each case as amended or supplemented from time to time, including, without limitation, all applicable judicial or administrative orders, applicable consent decrees and binding judgments relating to the regulation and protection of human health, safety, the environment and natural resources (including, without limitation, ambient air, surface, water, groundwater, wetlands, land surface or subsurface strata, wildlife, aquatic species and vegetation), including, without limitation, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (42 U.S.C. §§ 9601 et seq.), the Hazardous Material Transportation Act, as amended (49 U.S.C. §§ 1801 et seq.), the Federal Insecticide, Fungicide, and Rodenticide Act, as amended (7 U.S.C. §§ 136 et seq.), the Resource Conservation and Recovery Act, as amended (42 U.S. §§ 6901 et seq.), the Toxic Substance Control Act, as amended (15 U.S.C. §§ 2601 et seq.), the Clean Air Act, as amended (42 U.S.C. §§ 7401 et seq.), the Federal Water Pollution Control Act, as amended (33 U.S.C. §§ 1251 et seq.), the Occupational Safety and Health Act, as amended (29 U.S.C. §§ 651 et seq.), the Safe Drinking Water Act, as amended (42 U.S.C. §§ 300f et seq.), any state or local counterpart or equivalent of any of the foregoing, and any federal, state or local transfer of ownership notification or approval statutes. Purchaser acknowledges and agrees that the waivers, releases, and other provisions contained in Section 5 are a material factor in Seller’s acceptance of the Purchase Price and that Seller is unwilling to sell the Property to Purchaser unless Seller is released as expressly set forth above. Purchaser has fully reviewed the disclaimers, releases and waivers set forth in this Agreement and understands and accepts the significance and effect thereof.

 

5.9.    Purchaser releases Seller, the Seller Related Parties and their respective successors and assigns from and against any and all claims which Purchaser or any party related to or affiliated with Purchaser (each, a "Purchaser Related Party") has or may have arising from or related to any matter or thing related to or in connection with the Property, and if any Remediation is required after the Closing Date, it shall be performed at the sole cost and expense of Purchaser and Purchaser shall not seek reimbursement or compensation from Seller on account thereof in excess of the amounts set forth in this Agreements. This release shall be given full force and effect according to each of its express terms and provisions, including those relating to unknown and unsuspected claims, damages and causes of action. The provisions of this Section 5.9 shall survive the termination of this Agreement.

 

5.10.    This Section 5 shall survive Closing and termination of this Agreement and shall not be deemed to have merged into any of the documents executed or delivered at the Closing.

 

13

 

6.      Apportionments.

 

6.1.     At the Closing, the following items shall be apportioned between the parties as of 11:59 PM on the day preceding the Closing Date. Any errors in the apportionments pursuant to this Section 6 shall be corrected by appropriate re-adjustment between Seller and Purchaser after the Closing, provided that notice of any such error, with supporting calculations, shall be given by Purchaser to Seller or by Seller to Purchaser, as the case may be, no later than ninety (90) days after the Closing (if ascertainable within such period); it being understood and agreed that if any such items or errors are not ascertainable at the Closing or within ninety (90) days thereafter, the apportionment shall be made after the Closing within a reasonable time when the charge or error is determined. All apportionments shall be made in the manner recommended by the Customs in Respect to Title Closings of the Real Estate Board of New York, Inc., and there shall be no other apportionments. The items to be apportioned are:

 

6.1.1.     Payments in lieu of taxes (“PILOT”) and special assessments levied or imposed upon the Property in respect of the current fiscal year of the applicable taxing authority in which the Closing Date occurs (the "Current Tax Year"), on a per diem basis based upon the number of days in the Current Tax Year prior to the Closing Date (which shall be allocated to Seller) and the number of days in the Current Tax Year on and after the Closing Date (which shall be allocated to Purchaser). If the Closing shall occur before the tax rate for the Current Tax Year is fixed, the apportionment of PILOT payments and real estate taxes shall be upon the basis of the tax rate for the next preceding fiscal period applied to the latest assessed valuation. Promptly after the new tax rate is fixed for the fiscal period in which the Closing takes place, the apportionment of PILOT payments and real estate taxes shall be recomputed. If any assessments levied or imposed upon the Property are payable in installments, the installment for the Current Tax Year shall be prorated in the manner set forth above and Purchaser hereby assumes the obligation to pay any such installments due on and after the Closing Date. Purchaser acknowledges that (i) the Property is leased to the Town of Islip Industrial Development Agency, (ii) PILOT payments may terminate as of the Closing Date, and (iii) the Property will be restored to the real estate tax rolls and Purchaser shall be solely responsible for the payment of such restored real estate taxes as of the Closing Date.

 

6.1.2.    To the extent reimbursable by existing tenants under the Leases, charges and fees due under contracts for the supply to the Property of heat, steam, electric power, gas and light and telephone, if any, in respect of the billing period of the related service provider in which the Closing Date occurs (the "Current Billing Period") on a per diem basis based upon the number of days in the Current Billing Period prior to the Closing Date (which shall be allocated to Seller) and the number of days in the Current Billing Period on and after the Closing Date (which shall be allocated to Purchaser) and assuming that all charges are incurred uniformly during the Current Billing Period (it being agreed that all deposits, if any, made by Seller as security under any such public service contracts shall be credited to Seller if such amounts remain on deposit after the Closing for the benefit of Purchaser; provided, however, that Seller shall be entitled in its sole discretion to receive a refund of such security deposits directly from any such service provider without credit to Purchaser).

 

6.1.3.    Any charges or fees for transferable licenses and permits for the Property.

 

14

 

6.1.4.    Fuel, if any, then stored at the Property on the basis of Seller’s last cost therefor, including sales tax, as evidenced by a current written statement of Seller's fuel oil supplier, which statement shall be conclusive as to quantity and cost.

 

6.1.5.    [Intentionally omitted].

 

6.1.6.    Rents and additional rents (collectively “Rents”) under the Leases on an “if, as and when” collected basis. Rents collected by Seller or Purchaser after the Closing Date from tenants who owe Rents for periods prior to the Closing Date shall be applied (a) first, in payment of Rents due for all periods following the Closing Date, (b) second, in payment of Rents due for the calendar month in which the Closing Date occurs, and (c) third, in payment of Rents due for all periods prior to the Closing Date. Each such amount, less reasonable collection costs, shall be adjusted and prorated as provided above. From and after the Closing Date, Purchaser shall use commercially reasonable efforts (but shall not be required to commence litigation or terminate the related Lease) to collect from tenants any Rents that are delinquent as of the Closing Date, and upon request shall deliver to Seller updated collection reports on a monthly basis. Seller shall reimburse Purchaser’s reasonable fees and expenses incurred in such collection efforts authorized by Seller.

 

6.1.7.    All other items customarily apportioned in connection with the sale of commercial real estate in the State of New York.

 

6.1.8.    If there are water meters on the Property, Seller shall endeavor to furnish readings to a date not more than thirty (30) days prior to the Closing Date, and the unfixed meter charges and the unfixed sewer rents, if any, based thereon for the intervening time shall be apportioned on the basis of such last readings. If Seller fails or is unable to obtain such readings, the Closing shall nevertheless proceed and the parties shall apportion the meter charges and sewer rents for the Property on the basis of the last readings and bills received by Seller for the Property, provided that (i) such last readings and bills are dated not more than sixty (60) days prior to the Closing Date, and the same shall be appropriately readjusted after the Closing on the basis of the next subsequent bills, and (ii) Seller deposits sufficient funds in escrow with the Title Company to insure payment after Closing.

 

6.2.    The provisions of this Section 6 shall survive the Closing; provided, however, that any re-prorations or re-apportionments shall be made as and when required under Section 6.1 above.

 

7.            Representations and Warranties of the Parties. Certain Covenants.

 

7.1.    Seller represents to Purchaser that the following are true and correct on the date hereof and on the Closing Date:

 

15

 

7.1.1.    Seller has the requisite power and authority to enter into and to perform the terms of this Agreement. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all requisite action of Seller. This Agreement constitutes, and each document and instrument contemplated hereby to be executed and delivered by Seller, when executed and delivered, shall constitute the legal, valid and binding obligation of Seller enforceable against Seller in accordance with its respective terms (subject to bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally). The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby do not conflict with Seller’s by-laws or certificate of incorporation.

 

7.1.2.     Seller is a New York corporation duly formed and validly existing under the laws of the State of New York. Seller is not a "foreign person" within the meaning of Section 1445 of the Internal Revenue Code 1986, as amended, or any regulations promulgated thereunder (collectively, the "Code").

 

7.1.3.    Neither the execution, delivery and performance of this Agreement nor the consummation of the transactions contemplated hereby is prohibited by, or requires Seller to obtain any consent, authorization, approval or registration under any law, statute, rule, regulation, judgment, order, writ, injunction or decree which is binding upon Seller.

 

7.1.4.    [Intentionally omitted].

 

7.1.5.     The Property is leased to the Town of Islip Industrial Development Agency (“IDA”) and Seller shall apply to the IDA for a termination of the lease effective as of Closing.

 

7.1.6.    Seller is not a Blocked Person (as hereinafter defined), it being understood that Seller makes no representation with respect to any person or entity that owns an indirect equity interest in Seller by virtue of owning publicly traded securities. For purposes of this Agreement, a “Blocked Person” is any person or entity with whom U.S. persons or entities are restricted from doing business under regulations of the Office of Foreign Asset Control (“OFAC”) of the U.S. Department of the Treasury (including those named on OFAC’s Specially Designated and Blocked Persons List) or under any statute, executive order (including the September 24, 2001, Executive Order Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism), or other governmental action.

 

7.1.7.    Seller is not the subject of any voluntary or involuntary bankruptcy or similar insolvency proceeding or has received any written notice of any attachments, execution proceedings, assignments for the benefit of creditors, insolvency, bankruptcy, reorganization or of other proceedings now pending or, to Seller’s current actual knowledge, threatened against the Seller.

 

16

 

7.1.8.        Except for the Leases, Seller has not entered into any lease, license or occupancy agreement for the Property that will remain in effect after the Closing.

 

7.1.9         No person, entity or association, other than Seller and the tenant under the Leases, has any rights or possessory interest in the Property.

 

7.1.10         No person, entity or association has a right of first refusal, right of first offer or other similar right in respect of all or any space in the Property.

 

7.1.11         Seller has not granted any option rights or rights of first refusal with respect to acquisition of the Property.

 

7.1.12        To the Seller’s knowledge, there is no pending litigation affecting the Property or Seller which would adversely affect Seller’s ability to convey title to the Property as provided herein.

 

7.1.13        Seller has not transferred all or any portion of the air or other development rights appurtenant to the Property.

 

7.1.14         Seller has no pending proceedings or appeals to correct or reduce the assessed valuation of the Property for the current and prior tax years.

 

7.1.15         Seller has not received any written notice of any pending eminent domain proceedings which would affect all or any portion of the Property.

 

The representations and warranties of Seller set forth in this Agreement shall survive the Closing for six (6) months.

 

7.2.      When used in this Agreement or in any certificate or other document delivered pursuant hereto, the phrase “to the best of Seller's knowledge,” “to Seller's knowledge,” or derivations thereof shall be construed to mean the current, actual knowledge (as opposed to constructive or imputed knowledge) of Thomas McNeill, CFO, without any obligation to make investigation or inquiry regarding the Property, and without obligation to make any investigation of the files, documents or studies in the possession of other persons, and shall not include any knowledge which may be imputed to Seller or of any other person. Purchaser acknowledges that the individuals named above are named solely for the purpose of defining and narrowing the scope of Seller's knowledge and not for the purpose of imposing any liability on or creating any duties running from such individuals to Purchaser. Purchaser covenants that it will bring no action of any kind against such individuals, related to or arising out of these representations and warranties.

 

17

 

7.3.       No claim for damages for a misrepresentation or breach of warranty of Seller, irrespective of whether contained in this Agreement or in any certificate or other writing made by Seller, shall be actionable or payable, and Seller shall have no liability to Purchaser for any misrepresentation or breach of warranty of Seller, if Purchaser does not Close title to the Property. Furthermore, if Purchaser Closes title to the Property, no claim for damages for a misrepresentation or breach of warranty of Seller, irrespective of whether contained in this Agreement or in any certificate or other writing made by Seller, shall be actionable or payable, and Seller shall have no liability to Purchaser for (a) any condition, state of facts or other matter (i) which Purchaser or Purchaser’s officers, attorneys, consultants, or employees giving substantive attention to this Agreement or the Property (collectively and individually “Purchasers Agents”) had actual knowledge prior to Closing, or (ii) which is set forth in information or documents delivered or made available to Purchaser or Purchaser’s Agents irrespective of whether Purchaser or Purchaser’s Agents reviewed such information or documents, or (b) any misrepresentation or breach of warranty of Seller unless an action shall have been commenced by Purchaser against Seller no later than nine (9) months following the Closing Date. Purchaser further agrees that every otherwise applicable period of limitation to commence any action or proceeding for a misrepresentation or breach of warranty of Seller set forth in this Agreement shall be deemed to have expired within the time periods set forth above, which time periods shall not be subject to extension, enlargement or waiver by any means. If, prior to the Closing Date, Purchaser discovers that Seller has breached any of the material representations and warranties of Seller, Purchaser shall have the right to terminate this Agreement by written notice to Seller. If Purchaser duly terminates this Agreement pursuant to this Section, the Downpayment shall be promptly returned to Purchaser and neither party shall have any further rights or obligations pursuant to this Agreement, except Seller shall reimburse Purchaser for reasonable title search fees (without insurance), and reasonable survey costs.

 

7.4.        Purchaser represents to Seller that, subject to the terms and conditions of this Agreement, the following are true and correct on the date hereof:

 

7.4.1           Purchaser has the requisite power and authority to enter into and to perform the terms of this Agreement. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all requisite action of Purchase. This Agreement constitutes, and each document and instrument contemplated hereby to be executed and delivered by Purchaser, when executed and delivered, shall constitute the legal, valid and binding obligation of Purchaser enforceable against Purchaser in accordance with its respective terms (subject to bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally). The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby do not conflict with Purchaser’s by-laws or certificate of incorporation.

 

7.4.2.    Purchaser is not subject to any law, order, decree, restriction, or agreement which prohibits or would be violated by this Agreement or the consummation of the transactions contemplated hereby.

 

7.4.3.    Neither the execution, delivery and performance of this Agreement nor the consummation of the transactions contemplated hereby is prohibited by, or requires Purchaser to obtain any consent, authorization, approval or registration under any law, statute, rule, regulation, judgment, order, writ, injunction or decree which is binding upon Purchaser.

 

18

 

7.4.4.    There are no judgments, orders, or decrees of any kind against Purchaser unpaid or unsatisfied of record, nor any actions, suits or other legal or administrative proceedings pending or, to the best of Purchaser's actual knowledge, threatened against Purchaser, which would have any material adverse effect on the business or assets or the condition, financial or otherwise, of Purchaser or the ability of Purchaser to consummate the transactions contemplated by this Agreement.

 

7.4.5.    Purchaser is not a Blocked Person, it being understood that Purchaser makes no representation with respect to any person or entity that owns an indirect equity interest in Purchaser by virtue of owning publicly traded securities.

 

7.5  Seller covenants that between the date of this Agreement and the Closing:

 

(i)     Seller shall, at Seller’s sole cost and expense, maintain, or cause to be maintained, the Property in accordance with Seller’s past practices of operating, repair and condition, normal wear, tear and casualty excepted, to the extent same is not the obligation of Tenant under the Leases.

 

(ii)    Seller shall promptly provide Purchaser with a copy of any notice, citation, complaint or other directive from any person, entity or governmental or quasi-governmental authority whereby Seller’s compliance with environmental laws is called into question, and promptly notify Purchaser of any new information or other developments which could make any representation hereunder materially inaccurate.

 

8.         Closing Deliveries.

 

8.4.    At or prior to the Closing, Seller shall deliver to Escrow Agent the following documents (collectively, herein referred to as the “Sellers Closing Documents”):

 

8.4.2.    A statutory form of Bargain and Sale Deed sufficient to convey fee title to the Property subject to and in accordance with the provisions of this Agreement, in the form attached hereto as Exhibit C and made a part hereof (the “Deed”).

 

8.4.3.    All keys to any portion of the Property, to the extent in Seller's possession or control.

 

8.4.4.    A certificate, executed and acknowledged by Seller, in accordance with Section 1445 of the Code.

 

8.4.5.    Evidence of the authorization of the Seller to enter into and consummate the transactions described in this Agreement (including, e.g., copies of authorizing resolutions and/or consents as required based upon Seller’s organizational documents) along with evidence of authority of the person(s) executing this Agreement and the documents executed and delivered for and on behalf of the Seller to so execute and deliver the same.

 

19

 

8.4.6.    A Combined Real Estate Transfer Tax Return and Credit Line Mortgage Certificate, Form TP-584 (the "State Transfer Tax Return"), executed by Seller.

 

8.4.7.    A State of New York Real Property Transfer Report Form RP-5217, executed by Seller (“Equalization Form”).

 

8.4.8.    An Assignment and Assumption of Leases (the “Assignment Agreement”) in the form attached hereto and incorporated herein as Exhibit D.

 

8.4.9.    Notice to each tenant under the Leases, advising it of the sale of the Property to Purchaser, in the form attached hereto and incorporated herein as Exhibit E.

 

8.4.10.    An owner’s certificate from Seller in the form attached hereto and incorporated herein as Exhibit F.

 

8.4.11.    A Certificate of Subsisting Corporation of the Seller, as issued by the Secretary of the State of New York.

 

8.4.12.    A check or credit to Purchaser in the amount of any such security deposits, including accrued interest thereon, if any, held by Seller on the Closing Date, or an instrument transferring the security deposits to Purchaser.

 

8.4.13.    To the extent they are then in Seller's possession and not posted at the Property, certificates, licenses, permits, authorizations and approvals issued for or with respect to the Property by governmental and quasi-governmental authorities having jurisdiction.

 

8.4.14.    To the extent the same are in Seller's possession, Seller shall deliver all original Leases and any amendments or extensions thereto.

 

8.4.15.    Original Tenant Estoppel Certificates in the form annexed hereto as Exhibit G, dated no earlier than thirty (30) days prior to the first scheduled date of Closing.

 

8.4.16.    An assignment to Purchaser, without recourse, of all of the interest of Seller in and to the certificates, permits, approvals and other documents to be delivered to Purchaser at the Closing which are then in effect with respect to the Property and are assignable by Seller.

 

20

 

8.4.17.    A certificate of Seller confirming that the warranties and representations of Seller set forth in this Agreement are true and complete on and as of the Closing Date.

 

8.4.18.    Any other documents, instruments or agreements reasonably necessary to effectuate the transactions contemplated hereunder, in accordance with the express terms, covenants and conditions hereof.

 

8.5.    At or prior to the Closing, Purchaser shall pay the balance of the Purchase Price pursuant to Section 2.2 hereof and Purchaser shall execute, acknowledge and deliver or cause to be delivered the following documents (collectively, the “Purchasers Closing Documents”):

 

 

8.5.2.    A counterpart of the State Transfer Tax Return, executed by Purchaser.

 

8.5.3.    A counterpart of the Equalization Form, executed by Purchaser.

 

8.5.4.    A counterpart of the Assignment Agreement.

 

8.6.    Seller and Purchaser, at the Closing, shall prepare, execute and deliver to each other, subject to all the terms and provisions of this Agreement, (a) a closing statement setting forth, inter alia, the closing adjustments and material monetary terms of the transaction contemplated hereby and (b) such other instruments and documents as may be reasonably required to effectuate the consummation of the transactions described in this Agreement.

 

9.           Conditions to the Closing Obligations.

 

9.1.     Notwithstanding anything to the contrary contained in this Agreement, the obligation of Seller to convey the Property to Purchaser in accordance with this Agreement is expressly conditioned upon the fulfillment by and as of the Closing Date of each of the conditions listed below, provided that Seller, at its election, evidenced by notice delivered to Purchaser at or prior to the Closing, may waive any of such conditions:

 

9.1.1.    Purchaser shall have delivered to Escrow Agent the Net Purchase Price and other funds required hereunder and shall have executed, acknowledged and delivered to Escrow Agent all of the Purchaser’s Closing Documents, and such other documents and other items required pursuant to Section 8.2, at or prior to Closing.

 

9.1.2.    Purchaser shall have performed in all material respects all other covenants, undertakings and obligations to comply with all conditions required by this Agreement to be performed or complied with by Purchaser at or prior to Closing.

 

21

 

9.1.3.    All representations and warranties made by Purchaser in this Agreement shall be true and correct in all material respects as of the Closing Date.

 

9.2.    Notwithstanding anything to the contrary contained in this Agreement, the obligation of Purchaser to acquire the Property and pay the Purchase Price in accordance with this Agreement is expressly conditioned upon the fulfillment by and as of the Closing Date of each of the conditions listed below, provided that Purchaser, at its election, evidenced by notice delivered to Seller at or prior to the Closing, may waive all or any of such conditions:

 

9.2.1.    Seller shall have executed and delivered to Escrow Agent all of the Seller’s Closing Documents, and such other documents and other items required pursuant to Section 8.1, at or prior to Closing.

 

9.2.2.    All representations and warranties made by Seller in this Agreement shall be true and correct in all material respects as of the Closing Date, except to the extent the facts and circumstances underlying such representations and warranties may have changed as of the Closing. Notwithstanding the foregoing, if on the Closing Date any such representations and warranties are not true and correct in all material respects, Purchaser shall in any event be required to close hereunder and pay the Purchase Price to Seller unless the breach(es) of any representations and warranties will have, in the aggregate, a "material adverse effect" provided that in such event, Seller shall be entitled, at its option and in its sole discretion, to pay to Purchaser such amount on account of such breach(es) as will cause the same to no longer have a "material adverse effect", in which event Purchaser shall be required to close hereunder. As used herein, a "material adverse effect" shall be deemed to have occurred if by reason of such misrepresentation the fair market value of the Property is decreased by more than $150,000.

 

9.2.3.    The Title Company shall be willing to insure title to the Property pursuant to an ALTA 2006 Owner's Policy of Title Insurance as applicable in New York in the amount of the Purchase Price at regular rates and without additional premium (which shall not be deemed to include the cost of any endorsements to title requested by Purchaser), subject only to the Permitted Exceptions, and as otherwise provided in this Agreement (the "Title Policy").

 

10.          Seller’s Obligations as to Leases.

 

10.1.    From and after the Effective Date through the termination hereof or the Closing Date, Seller shall not (i) terminate any Lease except by reason of a default by the Tenant thereunder or in accordance with law, (ii) consent to the assignment of a Lease or subletting by any Tenant except as required by the terms of the applicable Lease or by law, or (iii) modify the term of a Lease, renew a Lease or enter into a new lease for a term extending beyond the Closing Date. Seller shall not grant any concessions or rent abatements for any period following the Closing Date without Purchaser’s prior written consent.

 

22

 

10.2.    Seller does not warrant that any particular Lease or tenancy will be in force or effect at the Closing or that the tenants will have performed their obligations thereunder. The termination of any Lease or tenancy prior to the Closing Date by reason of the tenant’s default shall not affect the obligations of Purchaser under this Agreement in any manner or entitle Purchaser to an abatement of or credit against the Purchase Price or give rise to any other claim on the part of Purchaser. If any space is vacant on the Closing Date, Purchaser shall accept the Property subject to such vacancy.

 

10.3.    Prior to the Closing, Seller shall have the right, but not the obligation, to enforce its rights against any tenant, by summary proceedings or in any other manner. Purchaser agrees that the dispossession or removal of any tenant prior to the Closing Date shall not be the basis for any claim on the part of Purchaser or affect the obligations of Purchaser under this Agreement in any manner whatsoever, and Purchaser shall close title and accept delivery of the deed with or without such tenant in possession, without any abatement against the Purchase Price, allowance or credit of any kind or any claim or right of action against Seller for damages or otherwise.

 

10.4.    The aggregate security deposit held by Seller under the Leases shall be turned over by Seller to Purchaser at the Closing by a credit to Purchaser against the Purchase Price. Seller shall not apply any security deposit of a Tenant in default under its Lease prior to Closing if such Tenant remains in possession of its premises at Closing.

 

10.5.    Seller has entered in brokerage fee agreements with Greiner-Maltz Co. of Long Island LLC and Ashlind Properties (collectively the “Leasing Brokers”) pursuant to which leasing commissions will be due to the Leasing Brokers if the existing tenants renew or extend their Leases. True, complete and correct copies of such brokerage fee agreements are annexed hereto as Exhibit B. Purchaser assumes the obligation to pay all leasing commissions payable to the Leasing Brokers accruing for all periods following the Closing Date, and to indemnify, defend and hold Seller harmless from and against the same. This provision shall survive Closing.

 

10.6.    Seller represents that (i) the copies of the Leases annexed hereto as Exhibit B are true, complete and correct copies of the Leases; (ii) as of the Effective Date all Leases are in full force and effect and none of them have been modified or amended except as set forth therein; (iii) the rents are being collected on a current basis and there are no arrearages in the payment of monthly fixed rent excess of one month; (iv) no tenant is entitled to rental concessions, abatements, deductions or offsets for any period subsequent to the scheduled date of Closing, except as set forth in the Leases; and (v) Seller has not sent written notice to any Tenant claiming that such Tenant is in default under its Lease, which default remains uncured.

 

10.7.    Seller represents that it is currently holding the security deposits in the aggregate sum of $137,916.66 in accordance with the Leases and there are no other security deposits.

 

23

 

10.8.     A portion of the Property is presently occupied by CVD Equipment Corporation and CVD Materials Corporation, (individually and collectively “CVD”) which are affiliates of Seller. Seller shall cause CVD to vacate the space occupied by CVD prior to Closing and such space shall be delivered to Purchaser at Closing in broom clean condition. Seller and CVD may remove any and all of “Seller’s Property” (hereinafter defined) from the Property prior to Closing. Seller shall repair any damage to the Property caused by such removal, but shall not be required to patch and fill bolt, screw and anchor holes in walls, floors and ceilings resulting from such removal. Seller shall cap all disconnected water, sewer and electrical connections. The term “Sellers Property” means all personal property, furnishings, machinery, trade fixtures, materials, supplies, equipment, and improvements (trade or otherwise) which Seller owns that are located on the Property and/or in the Improvements.

 

11.           Limitation on Liability of Parties.

 

11.1.    If Purchaser shall default in the performance of Purchaser's obligations under this Agreement and the Closing does not occur as a result thereof (a "Purchaser Default"), Seller's sole and exclusive remedy shall be, and Seller shall be entitled, to retain the Downpayment as and for full and complete liquidated and agreed damages for Purchaser's Default, and Purchaser shall be released from any further liability to Seller hereunder, except that the provisions of Sections 5.8, 13, 24, 25, 26 and 27 hereof shall survive. SELLER AND PURCHASER AGREE THAT IT WOULD BE IMPRACTICAL AND EXTREMELY DIFFICULT TO ESTIMATE THE DAMAGES WHICH SELLER MAY SUFFER UPON A PURCHASER DEFAULT AND THAT THE DOWNPAYMENT REPRESENTS A REASONABLE ESTIMATE OF THE TOTAL NET DETRIMENT THAT SELLER WOULD SUFFER UPON A PURCHASER DEFAULT. SUCH LIQUIDATED AND AGREED DAMAGES ARE NOT INTENDED AS A FORFEITURE OR A PENALTY WITHIN THE MEANING OF APPLICABLE LAW.

 

11.2.    Subject to the provisions of Section 3.4 hereof, if Seller shall default in the performance of Seller's obligations under this Agreement and the Closing does not occur as a result thereof, Purchaser's sole and exclusive remedy shall be, and Purchaser shall be entitled, to either (a) instruct Escrow Agent to pay to Purchaser the Downpayment (a "Downpayment Return"), upon which Seller shall be released from any further liability to Purchaser hereunder, except that the provisions of Sections 5.8, 13, 24, 25, 26 and 27 hereof shall survive or (b) (i) seek specific performance of Seller's obligations hereunder, provided that any such action for specific performance must be commenced within 180 days after such default, or (ii) instruct Escrow Agent to make a Downpayment Return plus cost of title report and new survey; in all of which events Seller shall, in no event whatsoever, be liable to Purchaser for any other damages of any kind whatsoever.

 

12.          Fire or Other Casualty; Condemnation.

 

12.1.    From the Effective Date until the Closing Date, Seller agrees to (a) maintain its present property insurance policy including fire and extended coverage and (b) give Purchaser reasonably prompt notice of any fire or other casualty occurring at the Property of which Seller obtains knowledge, or of any actual or threatened condemnation of all or any part of the Property of which Seller obtains actual knowledge.

 

24

 

12.2.    If prior to the Closing there shall occur (a) damage to the Property caused by fire or other casualty which would cost an amount equal to $500,000.00 or more to repair, as reasonably determined by an engineer selected by Seller which is satisfactory to Purchaser in the exercise of its reasonable judgment, or (b) a taking by condemnation of any portion of the Property, then, and in either such event, Purchaser may elect to terminate this Agreement by notice given to Seller within ten (10) days after Purchaser has received the notice referred to in Section 12.1 hereof, or at the Closing, whichever is earlier, in which event Seller shall promptly instruct Escrow Agent, to return the Downpayment and upon Purchaser's receipt of such Downpayment, this Agreement shall thereupon be null and void and neither party hereto shall thereupon have any further obligation to the other, except that the provisions of Sections 13, 24, 25, 26 and 27 hereof shall survive such termination. If Purchaser does not elect to terminate this Agreement, then the Closing shall take place as herein provided, without abatement of the Purchase Price, and Seller shall assign to Purchaser at the Closing, by written instrument in form reasonably satisfactory to Purchaser, all of Seller's interest in and to any insurance proceeds or condemnation awards which may be payable to Seller on account of any such fire, casualty or condemnation and Seller shall pay all deductibles and self-insured retention amounts relating thereto. If the insurance proceeds paid to Seller are in excess of the Purchase Price, then Seller’s Reimbursable Amounts shall be reduced by an amount equal to the Reimbursable Amount minus the difference between the amount of the Insurance Proceeds and the Purchase Price, provided that in no event shall the amount of the insurance proceeds paid to Purchaser exceed the Purchase Price. The term “Seller’s Reimbursable Amounts” as used herein means sums actually and reasonably expended or incurred by Seller in adjusting any insurance claim or negotiating and/or obtaining any condemnation award (including, without limitation, reasonable attorneys' fees and expenses) and/or theretofore actually and reasonably incurred or expended by or for the account of Seller for the cost of any compliance with laws, protective restoration or emergency repairs made by or on behalf of Seller (to the extent Seller has not theretofore been reimbursed by its insurance carriers for such expenditures).

 

12.3.    If, prior to the Closing, there shall occur damage to the Property caused by fire or other casualty which would cost less than $500,000.00 to repair, as reasonably determined by an engineer selected by Seller which is reasonably satisfactory to Purchaser in the exercise of its reasonable discretion then, neither party shall have the right to terminate its obligations under this Agreement by reason thereof, but Seller shall assign to Purchaser at the Closing, by written instrument in form and substance reasonably satisfactory to Purchaser, all of Seller's interest in any insurance proceeds or condemnation awards which may be payable to Seller on account of any such fire, casualty or condemnation, or shall deliver to Purchaser any such proceeds or awards actually theretofore paid, and Seller shall pay all deductibles and self-insured retention amounts relating thereto. The proceeds of rent interruption insurance, if any, shall on the Closing Date be appropriately apportioned between Purchaser and Seller.

 

12.4.    Nothing contained in this Section 12 shall be construed to impose upon Seller to repair any damage or destruction caused by fire or other casualty or condemnation.

 

25

 

12.5.    [intentionally omitted].

 

12.6.    If Purchaser does not elect to terminate this Agreement in accordance with Section 12.2 above, or upon the occurrence of the events set forth in Section 12.3 (a) or (b) above, Seller shall have the exclusive right to negotiate, compromise or contest the obtaining of any insurance proceeds and/or any condemnation awards.

 

13.          Brokerage.

 

Seller represents and warrants to Purchaser that it has not dealt with any broker, consultant, finder or like agent who might be entitled to a commission or compensation on account of introducing the parties hereto, the negotiation or execution of this Agreement or the closing of the transactions contemplated hereby other than Greiner-Maltz Co. of Long Isalnd, LLC and Tom Attivissimo (the "Broker"). Seller shall pay the commission due to Broker pursuant to a separate agreement. Purchaser represents and warrants to Seller that except for Broker, Purchaser has not dealt with or engaged any broker, consultant, finder or person that brought the Property to the attention of Purchaser or otherwise communicated with Purchaser with respect to the transaction contemplated hereby. Each party agrees to indemnify and hold harmless the other party from and against all claims, losses, liabilities and expenses (including, without limitation, reasonable attorneys' fees and disbursements) caused by or arising out of (a) a breach of any of the aforesaid representations and warranties of the indemnifying party; and (b) any claim for any commission or other compensation of any person or entity (other than Broker) claiming to have dealt with, on behalf of, through or under the indemnifying party. The provisions of this Section 13 shall survive the Closing or other termination of this Agreement.

 

14.          Closings Costs; Fees and Disbursements of Counsel, etc.

 

At the Closing, Seller shall pay the New York State Real Estate Transfer Tax imposed pursuant to Article 31 and Section 1402 of the New York Tax Law (the "State Transfer Tax"), upon or payable in connection with the transfer of the Property. Except as otherwise expressly provided to the contrary in this Agreement, Purchaser shall pay all title charges and survey costs, including the premium on Purchaser's Title Policy. Each of the parties hereto shall bear and pay the fees and disbursements of its own counsel, accountants and other advisors in connection with the negotiation and preparation of this Agreement and the Closing. The parties shall share the cost equally of the Title Company in connection with any escrow closing. The provisions of this Section 14 shall survive the Closing.

 

15.          Notices.

 

Except as otherwise provided in this Agreement, all notices, demands, requests, consents, approvals or other communications (for the purposes of this Section collectively referred to as "Notices") required or permitted to be given hereunder or which are given with respect to this Agreement, in order to constitute effective notice to the other party, shall be in writing and shall be deemed to have been given when (a) personally delivered with signed delivery receipt obtained, (b) when transmitted by email, if followed by delivery of, pursuant to one of the other means set forth in this Section 15 before the end of the first business day thereafter, printed confirmation of the successful transmission to the appropriate email address listed below as obtained by the sender from the sender's email account, (c) upon receipt, when sent by prepaid reputable overnight courier or (d) three (3) days after the date so mailed if sent postage prepaid by registered or certified mail, return receipt requested, in each case addressed as follows:

 

26

 

If to Seller, to:

555 N Research Corporation

 

355 South Technology Drive

 

Central Islip, NY 11722

 

Attention: Thomas McNeill, CFO

 

Telephone No: (631)981-7081 x2140

 

Email Address: tmcneill@cvdequipment.com

 

 

with a copy to:

Ruskin Moscou Faltischek, P.C.

 

East Tower, 15th Floor

 

1425 RXR Plaza

 

Uniondale, New York 11556-1425

 

Attention: Benjamin Weinstock, Esq.

 

Telephone No: (516) 663-6555

 

Email Address: bweinstock@rmfpc.com

 

 

If to Purchaser, to:

Steel K, LLC

 

c/o Steel Equities

 

999 South Oyster Bay Road

 

Suite 200

 

Bethpage, New York 11714

 

Attn: Joseph Lostritto

 

Telephone No: (516) 576-3165

 

Email Address: jlostritto@steelequities.com

 

 

with a copy to:

Frisoni Associates, PC

 

527 Townline Road

 

Suite 300

 

Hauppauge, New York 11788

 

Attn: Robert Frisoni, Esq.

 

Telephone.: (631)390-4343

 

Email Address: rfrisoni@frisonilaw.com

   

If to Escrow Agent, to:

Ruskin Moscou Faltischek, P.C.

 

East Tower, 15th Floor

 

1425 RXR Plaza

 

Uniondale, New York 11556-1425

 

Attention: Benjamin Weinstock, Esq.

 

Telephone No: (516) 663-6555

 

Email Address: bweinstock@rmfpc.com

 

27

 

Personal delivery to a party or to any officer, partner, member, agent or employee of such party at the foregoing addresses shall constitute receipt. Rejection or other refusal to accept or inability to deliver because of changed address of which no notice has been received shall also constitute receipt. Notices may be sent by the attorneys for the respective parties and each such notice so served shall have the same force and effect as if sent by such party. Notices shall be valid only if served in the manner provided in this Section 15.

 

16.          Survival; Governing Law; Waiver of Trial by Jury.

 

15.1 Except as otherwise expressly set forth in this Agreement, the provisions of this Agreement shall not survive the Closing.

 

15.2 This Agreement shall be governed by, interpreted under, and construed and enforced in accordance with, the laws of the State of New York applicable to transactions made and to be performed in the State of New York, without giving effect to any part of such law that would result in the selection or application of the law of any other jurisdiction. The Parties hereby irrevocably submit to the in personam jurisdiction of the Supreme Court of the State of New York in Suffolk County and the United States District Court for the Eastern District of New York, and any appellate courts related thereto, with respect to any action or proceeding between the Parties.

 

15.3 SELLER AND PURCHASER HEREBY EXPRESSLY WAIVE TRIAL BY JURY IN ANY LITIGATION ARISING OUT OF, OR CONNECTED WITH, OR RELATING TO, THIS AGREEMENT OR THE RELATIONSHIP CREATED HEREBY. WITH RESPECT TO ANY MATTER FOR WHICH A JURY TRIAL CANNOT BE WAIVED, THE PARTIES AGREE NOT TO ASSERT ANY SUCH CLAIM AS A COUNTERCLAIM IN, NOR MOVE TO CONSOLIDATE SUCH CLAIM WITH, ANY ACTION OR PROCEEDING IN WHICH A JURY TRIAL IS WAIVED.

 

17.         Counterparts; Captions.

 

This Agreement may be executed in counterparts, each of which shall be deemed an original. Signatures on copies of this Agreement transmitted electronically shall be deemed originals for all purposes. Facsimile and electronic signatures of the parties, and signatures transmitted in .pdf format, shall be deemed to be original signatures of the parties. The captions are for convenience of reference only and shall not affect the construction to be given any of the provisions hereof

 

18.          Entire Agreement; No Third Party Beneficiaries.

 

This Agreement (including all exhibits annexed hereto) contains the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior understandings, if any, with respect thereto. This Agreement may not be modified, changed, supplemented or terminated, nor may any obligations hereunder be waived, except by written instrument signed by the party to be charged or by its agent duly authorized in writing or as otherwise expressly permitted herein. The parties do not intend to confer any benefit hereunder on any person or entity other than the parties hereto. The provisions of this Section 18 shall survive the Closing.

 

28

 

19.          Waivers; Extensions.

 

No waiver of any breach of any agreement or provision herein contained shall be deemed a waiver of any preceding or succeeding breach thereof or of any other agreement or provision herein contained. No extension of time for performance of any obligations or acts shall be deemed an extension of the time for performance of any other obligations or acts.

 

20.          No Recording.

 

Except in the case of a specific performance action, the parties hereto agree that neither this Agreement nor any memorandum or notice hereof shall be recorded. Any recordation or attempted recordation by Purchaser shall be void and shall constitute a material default by Purchaser.

 

21.          Assignment.

 

Purchaser shall neither assign its rights nor delegate its obligations hereunder directly or indirectly, without obtaining Seller's prior written consent, which consent may be granted or withheld in Seller's sole discretion. Notwithstanding anything to the contrary contained in this Section 21, Purchaser may assign this Agreement simultaneously with Closing to any Affiliate (as hereinafter defined) of Purchaser. In connection with any assignment permitted or consented to hereunder, such assignee shall assume in writing all of the Purchaser's obligations under this Agreement in form and substance reasonably satisfactory to Seller, provided that Purchaser originally named herein shall not be relieved from its obligations under this Agreement. Any other purported or attempted assignment or delegation without obtaining Seller's prior written consent or not otherwise permitted hereunder shall be void and of no effect. For purposes of this Section 21, the term (a) "Affiliate" means (i) any corporation, limited liability company, partnership or trust in which Joseph Lostritto and Glen Lostritto and/or members of their respective families owns or controls more than fifty percent (50%) of the beneficial and management interest. No consent given by Seller to any transfer or assignment of Purchaser's rights or obligations hereunder shall be construed as a consent to any other transfer or assignment of Purchaser's rights or obligations hereunder. No consent given by Seller to any transfer or assignment of Purchaser's rights or obligations hereunder shall be construed as a consent to any other transfer or assignment of Purchaser's rights or obligations hereunder. Purchaser shall not resell the Property or any part thereof through a "double escrow" or other similar procedure without Seller's prior written consent, which consent may be granted or withheld in Seller's sole discretion. No transfer or assignment in violation of the provisions hereof shall be valid or enforceable.

 

29

 

22.          Pronouns; Joint and Several Liability.

 

All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the identity of the parties may require. If Purchaser consists of two or more parties, the liability of such parties shall be joint and several.

 

23.          Successors and Assigns:

 

This Agreement shall bind and inure to the benefit of Seller, Purchaser and their respective permitted successors and assigns.

 

24.          Escrow.

 

24.1.      Escrow Agent shall hold and disburse the Downpayment in accordance with the following provisions:

 

24.1.1.    If so directed by Seller, Escrow Agent shall hold the Downpayment in escrow in an interest bearing money market account until the Closing or sooner termination of this Agreement and shall pay over or apply such proceeds in accordance with the terms of this Section 24. A Form W-9 must be completed and executed by Seller and Purchaser concurrently with the execution of this Agreement. The failure to submit to Escrow Agent an executed, completed Form W-9 shall stay Escrow Agent’s obligation to deposit the escrow in an interest bearing account until such time that said form has been provided to Escrow Agent. If the Downpayment is held in a money market account, dividends thereon shall be treated, for purposes of this Section 24, as interest. Escrow Agent shall not be responsible for any diminution in value of the Downpayment, loss of any principal or interest thereon, or penalties incurred with respect thereto, for any reason whatsoever, provided that the Downpayment has been invested by Escrow Agent as hereinabove provided.

 

24.1.2.    If the Closing occurs, then Escrow Agent shall deliver the Downpayment to Seller.

 

24.1.3.    If Escrow Agent receives a notice signed by Purchaser or Seller (the "Noticing Party") stating that this Agreement has been canceled or terminated and that the Noticing Party is entitled to the Downpayment, or that the other party hereto. (the "Non-Noticing Party") has defaulted in the performance of its obligations hereunder, Escrow Agent shall deliver a copy of such notice to the Non-Noticing Party. The Non-Noticing Party shall have the right to object to such request for the Downpayment by notice of objection delivered to and received by Escrow Agent ten (10) business days after the date of Escrow Agent's delivery of such copy to the Non-Noticing Party, but not thereafter. If Escrow Agent shall not have so received a notice of objection from the Non-Noticing Party, Escrow Agent shall deliver the Downpayment to the Noticing Party. If Escrow Agent shall have received a notice of objection from the Non-Noticing Party within the time herein prescribed, Escrow Agent shall, at its sole option, either (i) deliver to the court the Downpayment; or (ii) retain the Downpayment until one of the following events shall have occurred: (a) the Non-Noticing Party shall have failed to commence an action in a court of competent jurisdiction against the Noticing Party to resolve why the Noticing Party shall not be entitled to the payment of the Downpayment within one hundred eighty (180) days after delivery of the Noticing Party's notice, by serving a summons and complaint on the Noticing Party and delivering to Escrow Agent a copy thereof, together with an affidavit of service within such one hundred eighty (180) day period, in which event Escrow Agent shall pay over the Downpayment to the Noticing Party; (b) there shall have been served upon Escrow Agent an order or judgment duly entered in a court of competent jurisdiction setting forth the manner in which the Downpayment is to be paid out and delivered, in which event Escrow Agent shall deliver the Downpayment as set forth in such order or judgment; or (c) Seller and Purchaser shall have delivered to Escrow Agent a joint statement executed by both Seller and Purchaser setting forth the manner in which the Downpayment is to be paid out and delivered, in which event Escrow Agent shall deliver the Downpayment as set forth in such statement. Escrow Agent shall not be or become liable in any way or to any person for its refusal to comply with any such requests or demands by Seller and Purchaser until and unless it has received a direction of the nature described above.

 

30

 

24.2.    Any notice to Escrow Agent shall be sufficient only if received by Escrow Agent within the applicable time period set forth herein. All mailings and notices from Escrow Agent to Seller and/or Purchaser, or from Seller and/or Purchaser to Escrow Agent, provided for in this Section 24 shall be addressed to the party to receive such notice at its notice address set forth in Section 15 above (with copies to be similarly sent to the additional persons therein indicated).

 

24.3.    Notwithstanding the foregoing, if Escrow Agent shall have received a notice of objection as provided for in Section 24.1.3 within the time therein prescribed, or shall have received at any time before actual disbursement of the Downpayment a notice signed by either Seller or Purchaser disputing entitlement to the Downpayment or shall otherwise believe in good faith at any time that a disagreement or dispute has arisen between the parties hereto over entitlement to the Downpayment (whether or not litigation has been instituted), Escrow Agent shall have the right, upon notice to both Seller and Purchaser, (a) to deposit the Downpayment with the Clerk of the Court in which any litigation is pending and/or (b) to take such reasonable affirmative steps as it may, at its option, elect in order to terminate its duties as Escrow Agent, including, without limitation, the depositing of the Downpayment with a court of competent jurisdiction and the commencement of an action for interpleader, the costs thereof to be borne by whichever of Seller or Purchaser is the losing party, and thereupon Escrow Agent shall be released of and from all liability hereunder except for any previous gross negligence or willful misconduct.

 

24.4.    Escrow Agent is acting hereunder without charge as an accommodation to Purchaser and Seller, it being understood and agreed that Escrow Agent shall not be liable for any error in judgment or any act done or omitted by it in good faith or pursuant to court order, or for any mistake of fact or law. Escrow Agent shall not incur any liability in acting upon any document or instrument believed thereby to be genuine. Escrow Agent is hereby released and exculpated from all liability hereunder, except only for willful misconduct or gross negligence. Escrow Agent may assume that any person purporting to give it any notice on behalf of any party has been authorized to do so. Escrow Agent shall not be liable for, and Purchaser and Seller hereby jointly and severally agree to indemnify Escrow Agent against, any loss, liability or expense, including reasonable attorneys' fees (either paid to retained attorneys or, representing the fair value of legal services rendered by Escrow Agent to itself), arising out of any dispute under this Agreement, including the cost and expense of defending itself against any claim arising hereunder.

 

31

 

24.5.    Escrow Agent may at any time resign hereunder by giving notice of its resignation to the parties at least fifteen (15) days prior to the date specified for such resignation to take effect and, upon the effective date of such resignation, the Downpayment shall be delivered by Escrow Agent to such person or entity as the parties may have jointly designated in writing or to such person or entity as may be designated as hereinafter provided as the successor Escrow Agent, whereupon all duties and obligations of Escrow Agent named herein shall cease and terminate. If no such person or entity shall have been designated by the parties by the date which is five (5) days prior to the date specified for such resignation to take effect then Escrow Agent may designate a bank in New York City that is a member of the New York City Clearinghouse Association to act as escrow agent hereunder.

 

25.          Confidentiality.

 

25.1.    Seller and Purchaser covenant and agree not to communicate the terms or any aspect of this Agreement and the transactions contemplated hereby to any person or entity and to hold, in the strictest confidence, the content of any and all information in respect of the Property which is supplied by Seller to Purchaser or by Purchaser to Seller, without the express written consent of the other party; provided, however, that either party may, without consent, disclose the terms hereof and the transactions contemplated hereby (a) to its respective advisors, consultants, attorneys, accountants, partners, investors, insurance agents, prospective tenants and lenders (the "Transaction Parties") without the express written consent of the other party, so long as any such Transaction Parties to whom disclosure is made shall also agree to keep all such information confidential in accordance with the terms hereof and (b) if disclosure is required by law or by regulatory or judicial process or pursuant to any regulations promulgated by the New York Stock Exchange or other public exchange for the sale and purchase of securities, provided that in such event Seller or Purchaser, as applicable, shall notify the other party in writing of such required disclosure, shall exercise all commercially reasonable efforts to preserve the confidentiality of the confidential documents or information, as the case may be, including, without limitation, reasonably cooperating with the other party to obtain an appropriate order or other reliable assurance that confidential treatment will be accorded such confidential documents or information, as the case may be, by such tribunal and shall disclose only that portion of the confidential documents or information which it is legally required to disclose. If this Agreement is terminated, such confidentiality shall be maintained and Seller, Purchaser and the Transaction Parties will destroy or deliver to Seller or Purchaser, as applicable, upon request, all documents and other materials, and all copies thereof, obtained thereby in connection with this Agreement that are subject to such confidence, with any such destruction confirmed by Seller or Purchaser, as applicable, and the Transaction Parties in writing. The foregoing confidentiality obligations shall not apply to the extent that any such information is a matter of public record or is provided in other sources readily available to the real estate industry other than as a result of disclosure by Seller or Purchaser, as applicable, or the Transaction Parties. Purchaser hereby indemnifies Seller against, and holds Seller harmless from, any and all claims, losses, damages, liabilities and expenses (including, without limitation, reasonable attorneys' fees and disbursements) arising in connection with Purchaser's obligations under this Section 25. The provisions of this Section 25 shall survive the Closing or the earlier termination of this Agreement.

 

32

 

25.2.    Purchaser and Seller agree that prior to the expiration of the Environmental Diligence Period, Purchaser and Purchaser’s Representatives shall not communicate verbally or in writing, including electronic communication such as email or texting, directly with the exiting tenants or their officers, principals or representative’s (a) unless Seller participates in such communication, and (b) such communication shall not state, suggest or imply that the tenant can relocate to any other property owned or managed by Purchaser or its affiliates.

 

26.          Further Assurances.

 

The parties each agree to do such other and further acts and things, and to execute and deliver such instruments and documents (not creating any obligations additional to those otherwise imposed by this Agreement) as either may reasonably request from time to time, whether at or after the Closing, in furtherance of the purposes of this Agreement. The provisions of this Section 26 shall survive the Closing.

 

27.          Miscellaneous.

 

27.1.    Where this Agreement by its terms requires the payment of money or the performance of a condition or an act, or the giving of notice, on a day that is not a business day (as defined below), such payment may be made or condition or act performed, or notice given, on the next business day, with the same force and effect as if made or performed in accordance with the terms of this Agreement. Unless otherwise expressly provided in this Agreement, any reference herein to time periods of fewer than seven (7) days will in the computation thereof exclude days that are not business days. Wherever used in this Agreement, the term “business day” means Monday through Friday, excluding holidays when New York State chartered, or federally chartered banks in New York, are closed.

 

27.2.    Purchaser agrees that notwithstanding any other provision of this Agreement, Purchaser shall look solely to the estate and property of Seller in the Property for the satisfaction of any of Purchaser’s remedies in the event of any default or breach by Seller with respect to any of the terms, covenants and conditions of this Agreement, and no other property or assets of Seller or any agent, member, manager, shareholder, director, officer, trustee, employee, partner, principal or beneficiary thereof, disclosed or undisclosed, shall be subject to levy, execution or other enforcement procedure for the satisfaction of Purchaser’s remedies, if any.

 

27.3.    Whenever the terms “include” or “including” are used in this Agreement, such terms shall be interpreted and shall read as “include without limitation” or “including without limitation” unless the context expressly requires an interpretation and reading limited to a specific reference or example.

 

33

 

27.4.    Seller and Purchaser acknowledge and agree that this Agreement has been reviewed and negotiated by both parties and their respective counsel, and that, in any dispute over the meaning, interpretation, validity or enforceability of this Agreement or any of its terms or conditions, there shall be no presumption whatsoever against either party by virtue of that party having drafted this Agreement or any portion thereof. If any words or phrases in this Agreement (or in any prior draft thereof) shall have been stricken out or otherwise eliminated, whether or not any other words or phrases have been added, this Agreement shall be construed as if the words or phrases so stricken out or otherwise eliminated were never included herein and no implication or inference shall be drawn from the fact that such words or phrases were so stricken out or otherwise eliminated.

 

27.5.    Neither the preparation and transmittal of this Agreement, nor any negotiation or modification of this Agreement with a prospective Purchaser, shall constitute an offer to sell and shall not be binding upon or enforceable against Seller unless and until the Agreement has been duly executed by Seller and a fully executed original counterpart has been delivered to Purchaser or Purchaser’s attorney.

 

27.6.    All riders, exhibits or schedules and other documents annexed to this Agreement or referenced in this Agreement are incorporated in this Agreement and made a part thereof as though set forth at length in this Agreement. If the provisions of any exhibit or schedule to this Agreement are inconsistent with the provisions of this Agreement, the provisions of such exhibit or schedule shall prevail.

 

27.7.    If any provision of this Agreement is invalid or unenforceable as against any person or under certain circumstances, the remainder of this Agreement, and the applicability of such provision to other persons or circumstances, shall not be affected thereby. Each provision of this Agreement, except as otherwise herein or therein provided, shall be valid and enforced to the fullest extent permitted by law.

 

27.8.    Any failure by either party to insist upon the strict performance by the other of any of the provisions of this Agreement shall not be deemed a waiver of any of the provisions hereof, and each party, notwithstanding any such failure, shall have the right thereafter to insist upon the strict performance by the other party of any and all of the provisions of this Agreement to be performed by such party.

 

27.9.    (a) Purchaser and its agents, employees, appraisers, bankers, prospective tenants, engineers and contractors (collectively, “Purchasers Representatives”) shall have the right from time to time, upon reasonable prior notice, subject to the rights of tenants, to enter upon and pass through the Property during normal business hours, only in the presence of and when accompanied by a representative of Seller. No Testing or sampling shall be conducted at the Property. Notwithstanding any such access, or anything to the contrary herein contained, Purchaser’s obligations hereunder shall not be limited or otherwise affected as a result of any fact, circumstance or other matter of any kind discovered following the date hereof in connection with any such inspection, access or otherwise; it being agreed that Seller is permitting Purchaser such access as a courtesy to Purchaser in its preparation for taking title to the Property. This Section 27.9 shall survive Closing or the earlier termination of this Agreement.

 

34

 

(b) Purchaser shall indemnify, defend and hold Seller harmless from any and all damages, losses, liabilities costs and reasonable expenses (including, without limitation, reasonable attorneys’ fees) incurred by arising from the negligent actions or omissions of Purchaser and Purchaser’s Representatives. Prior to any access to the Premises, Purchaser shall obtain, maintain, at its expense, commercial general liability insurance, including a contractual liability endorsement, and personal injury liability coverage, with Seller as additional insured, from an insurer reasonably acceptable to Seller, which insurance policies must have limits for bodily injury and death of not less than Two Million Dollars ($2,000,000.00) for any one (1) occurrence and not less than Two Million Dollars ($2,000,000.00) for property damage liability for any one (1) occurrence. Prior to making any entry upon the Premises, Purchaser shall furnish to Seller a certificate of insurance evidencing the foregoing coverages.

 

28.          IDA.

 

28.1.    The Parties acknowledge and agree that Seller has entered into a Straight Lease Transaction (the “Existing IDA Transaction”) with the Town of Islip Industrial Development Agency (the “IDA”) pursuant to which Seller receives certain real estate tax exemptions pursuant to a Payment in Lieu of Taxes program. The parties further acknowledge and agree that Purchaser intends to apply to the IDA for either (a) the IDA’s consent to the assignment of Seller’s rights under the Existing IDA Transaction to Purchaser and the assumption by Purchaser of Seller’s obligations thereunder (the “IDA Assignment”), or (b) a new Straight Lease Transaction for the provision of real estate tax exemptions, mortgage recording tax exemptions and/or sales and use tax exemptions (the “New IDA Transaction”). The IDA’s approval of either of IDA Assignment or the New IDA Transaction shall be hereinafter referred to as the “IDA Approval”. The parties further acknowledge and agree that Seller intends to apply to the IDA for a modification of a related IDA Straight Lease Transaction affecting the property at 355 South Technology Drive, Central Islip, New York 11722 (the 355 “Approval”) which is owned by an affiliate of Seller.

 

28.2.     The parties agree that the IDA Approval and the 355 Approval shall not be a condition precedent or a contingency to Purchaser’s or Seller’s obligation to Close title to the Property in accordance with this Agreement, and the failure to obtain the IDA Approval and/or the 355 Approval shall not relieve either party from any obligations under this Agreement. The parties’ agreement that obtaining the IDA Approval and the 355 Approval are not conditions precedent or contingencies to the performance of this Agreement is a material inducement by each to the other knowingly relied upon entering into this Agreement.

 

28.3.    Seller and Purchaser have agreed to mutually cooperate no cost, expense or liability to such party except as set forth in this Agreement, with the other party’s efforts to obtain the IDA Approval and the 355 Approval, as the case may be. In connection with obtaining the IDA Approval and the 355 Approval, the Parties agree as follows:

 

28.3.1         Purchaser shall promptly submit an application (on the IDA’s current application form) and such other submissions as may be required by the IDA for the IDA Approval.

 

28.3.2 Seller shall promptly submit an application (on the IDA’s current application form) and such other submissions as may be required by the IDA for the 355 Approval.

 

35

 

28.3.3          The parties shall make diligent and commercially reasonable efforts to obtain the IDA Approval and the 355 Approval from the IDA as soon as reasonably possible after the Effective Date, including, without limitation, the attendance by the parties at such meetings and/or phone interviews as may be required by the IDA;

 

28.3.4          If Purchaser obtains an IDA Approval for the IDA Assignment, Seller shall, at Closing, assign, without recourse, all of its rights, title and interest in and to all documents, instruments and agreements evidencing the Existing IDA Transaction (the “Existing IDA Documents”) to Purchaser and Purchaser shall assume all of Seller’s obligations under the Existing IDA Documents arising from and after the date of Closing. It shall be a condition of the Seller’s obligation to assign its rights to the Existing IDA Documents that Seller and any guarantor be released from all of its obligations under the Existing IDA Documents arising from and after the Closing.

 

28.3.5 If Purchaser obtains an IDA Approval for a New IDA Transaction, Seller shall cooperate with Purchaser in terminating the Existing IDA Documents and closing the New IDA Transaction and execute any documents, instruments and/or agreements reasonably required by the IDA in connection therewith.

 

28.3.6 If Purchaser does not obtain an IDA Approval or elects to proceed without the IDA Assignment or a New IDA Transaction, Seller shall cause the Existing IDA Documents to be terminated as of Closing and shall pay any recapture and/or processing charges assessed by the IDA.

 

28.4.    Purchaser shall be responsible for the payment of the fees charged by the IDA or the IDA’s counsel in connection with obtaining the IDA Approval. Each party shall pay the fees and disbursements of their own counsel with respect to the IDA Approval and the closing of the IDA Assignment or New IDA Transaction, as the case may be.

 

28.5.    Seller shall be responsible for the payment of the fees charged by the IDA or the IDA’s counsel in connection with obtaining the 355 Approval. Each party shall pay the fees and disbursements of their own counsel with respect to the 355 Approval and the Closing of the 355 Approval.

 

 

[The balance of this page is intentionally left blank. Signatures follow.]

 

36

 

 

IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the day and year first above written.

 

 

SELLER:

   
 

555 N RESEARCH CORPORATION

   
   
 

By:________________________________

 

Name:

 

Title:

   
   
   
 

PURCHASER:

   
 

STEEL K, LLC

   
 

By:________________________________

 

Name:

 

Title:

 

37

 

 

RECEIPT OF DOWNPAYMENT

AND AGREEMENT OF ESCROW AGENT

 

Escrow Agent hereby acknowledges the receipt of one (1) fully signed and executed copy of this Agreement.

 

Upon receipt, the Escrow Agent agrees to hold the Downpayment in for the benefit of Seller and Purchaser and to dispose of the Downpayment in accordance with the terms and provisions of this Agreement.

 

 

Ruskin Moscou Faltischek, PC

   
 

By:_______________________________

 

Name: Benjamin Weinstock

 

Title: Shareholder

 

38

 

EXHIBIT A

 

Legal Description

 

ALL that certain plot piece or parcel of land, with the buildings and improvement erected, situate, lying and being at Central Islip, in the Town of Islip, County of Suffolk, State of New York, known and designated as Lots 5, 6 and 7 on a certain map entitled "Map of Tech Park", filed in the Office of the Clerk of Suffolk County, which said map was filed on October 30, 1992 as Map No. 9282, being more particularly bounded and described as follows:

 

BEGINNING at the point formed by the intersection of the westerly line of North Champlin Drive with the northerly line of North Research Place:

 

RUNNING THENCE from said point of beginning the following two (2) courses and distances:

l ). South 81 degrees 30 minutes 3.7 seconds West, a distance of 834.82 feet along the northerly line of North Research Place to a point of curve;

2). Southwesterly along a curve to the left having a radius of 283 .00 feet, a distance of 119.02 feet to the division line between Lot 7 and Lot 8 on said map;

 

THENCE along said division line, the following two (2) courses and distances:

1). North 55 degrees 08 minutes 36 seconds West, 129.29 feet;

2). North 11 degrees 47 minutes 48 seconds West, 348.01 feet to a point on the southerly line of "Map of College Woods Section 2", filed 3/4/91 as Map No. 9071.

 

THENCE along said southerly line of "Map of College Woods, Section 2", North 72 degrees 54 minutes 33 seconds East, a distance of 1106.21 feet to a point;

 

THENCE South 39 degrees 24 minutes 19 seconds East, a distance of 136.64 feet to a point on the westerly line of North Champlin Drive;

 

THENCE along westerly line of North Champlin Drive, the following four (4) courses and distances:

1). South 13 degrees 29 minutes 54 seconds East, a distance of 137.77 feet to point;

2). Along the arc of a curve, bearing to the right having a radius of 975.00 feet, a distance of 85.23 feet to a point;

3). South 08 degrees 29 minutes 23 seconds East, a distance of 148.26 feet to a point;

4). Along the arc of a curve, bearing to the right, having a radius of 25 . 00 feet, a distance of 39.27 feet to the point or place of BEGINNING.

 

TOGETHER with a non-exclusive easement for ingress and egress, in and over described parcel:

 

 

 

ALL that certain plot, piece or parcel of land, situate, lying and being in Central Islip in the Town of Islip, County of Suffolk and State of New York, being a portion of Lot 4 on a certain map entitled, Map of Tech Park" filed in the Office of the Clerk of the County of Suffolk, filed October 30, 1992 as Map No. 9282, being more particularly bounded and described as follows:

 

BEGINNING at a point on the westerly side of North Champlin Drive where the same is intersected by the division line between Lot 4 and Lot 5 on said map;

 

RUNNING THENCE along the westerly side of North Champlin Drive, North 13 degrees, 29 minutes 54 seconds West, 126.66 feet to a point;

 

THENCE through Lot 4 on said map, South 72 degrees 54 minutes 33 seconds West, 59.82 feet to a point on the division line between Lot 4 and Lot 5 on said map;

 

THENCE along the division line, South 39 degrees 24 minutes 19 seconds East, 136.64 feet to the point or place of BEGINNING.

 

Premises commonly known as 555 N Research Place, Central Islip, New York 11722.

 

 

 

 

EXHIBIT B

 

Leases and Leasing Brokerage

 

 

1.

Leases.

 

 

(a)

Lease dated November 23, 2020 (the “Eastside Lease”) by and between the Seller, as landlord, and Elm Freight Handlers Inc., D/B/A Elm Global Logistics, as tenant.

 

 

(b)

Lease dated May 31, 2019, as extended by notice of the exercise of the second lease option from tenant Seller dated November 19, 2020, (the “Westside Lease”), by and between Seller, as landlord, and Elm Freight Handlers Inc., D/B/A Elm Global Logistics, as tenant.

 

 

 

2.

Leasing Brokerage

 

 

 

(a)

Brokerage Agreement among Seller, Greiner-Maltz Co. of Long Island LLC, and Ashlind Properties for the Eastside Lease.

 

 

(b)

Brokerage Agreement among Seller, Greiner-Maltz Co. of Long Island LLC, and Ashlind Properties for the Westside Lease.

 

 

 

EXHIBIT C

 

CONSULT YOUR LAWYER BEFORE SIGNING THIS INSTRUMENT - THIS INSTRUMENT SHOULD BE USED BY LAWYERS ONLY.

 

THIS INDENTURE, made the ____ day of ______, two thousand and twenty-one

 

BETWEEN         

____________________, a New York corporation, having an address at ____________________________ party of the first part, and

 

______________, a _______________ company, having an address at __________________________________ party of the second part,

 

WITNESSETH, that the party of the first part, in consideration of ten dollars and other valuable consideration paid by the party of the second part, does hereby grant and release unto the party of the second part, the heirs or successors and assigns of the party of the second part forever,

 

ALL that certain plot, piece or parcel of land, with the buildings and improvements thereon erected, situate, lying and being in the STATE OF NEW YORK, bounded and described more particularly as set forth in Schedule A annexed hereto and made a part hereof;

 

See SCHEDULE A annexed hereto.

 

PREMISES known as 555 North Research Place, Central Islip, New York 11722.

 

TOGETHER with all right, title and interest, if any, of the party of the first part in and to any streets and roads abutting the above described premises to the center of the lines thereof; TOGETHER with the appurtenances and all the estate and rights of the party of the first part in and to the premises, including all development rights, if any; TO HAVE AND TO HOLD the premises herein granted unto the party of the second part, the heirs or successors and assigns of the party of the second part forever.

 

AND the party of the first part, in compliance with Section 13 of the Lien Law, covenants that the party of the first part will receive the consideration for this conveyance and will hold the right to receive such consideration as a trust fund to be applied first for the purpose of paying the cost of improvement and will apply the same first to the payment of the cost of the improvement before using any part of the total of the same for any other purpose.

 

The word "party" shall be construed as if it read "parties" whenever the sense of this indenture so requires.

 

IN WITNESS WHEREOF, the party of the first part has duly executed this deed the day and year first above written.

 

IN PRESENCE OF:         

 

  By:________________________________

 

 

 

 

STATE OF NEW YORK )
   
COUNTY OF ____________   ss:

 

On the ____ day of ____________ in the year 2021, before me, the undersigned a notary public in and for said state, personally appeared _________________, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.

 

 

_____________________________

Notary Public

 

STATE OF NEW YORK )
   
COUNTY OF ____________   ss:

 

On the ____ day of ____________ in the year 2021, before me, the undersigned a notary public in and for said state, personally appeared _________________, personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity, and that by his signature on the instrument, the individual, or the person upon behalf of which the individual acted, executed the instrument.

 

 

 

_____________________________

Notary Public

 

 

 

BARGAIN AND SALE DEED

WITHOUT COVENANTS

AGAINST GRANTORS ACTS

 

 

TITLE NO.

 ══════════════════════════════════════════════════════

 

- to -

 

 ══════════════════════════════════════════════════════

 

WARD:

RETURN BY MAIL TO:

BLOCK:

 

LOT:

 

COUNTY:

 

TAX BILLING ADDRESS:

 

 

Record at the Request of the

Title Co.

 

 

 

 

 

Schedule A

 

ALL that certain plot piece or parcel of land, with the buildings and improvement erected, situate, lying and being at Central Islip, in the Town of Islip, County of Suffolk, State of New York, known and designated as Lots 5, 6 and 7 on a certain map entitled "Map of Tech Park", filed in the Office of the Clerk of Suffolk County, which said map was filed on October 30, 1992 as Map No. 9282, being more particularly bounded and described as follows:

 

BEGINNING at the point formed by the intersection of the westerly line of North Champlin Drive with the northerly line of North Research Place:

 

RUNNING THENCE from said point of beginning the following two (2) courses and distances:

l ). South 81 degrees 30 minutes 3.7 seconds West, a distance of 834.82 feet along the northerly line of North Research Place to a point of curve;

2). Southwesterly along a curve to the left having a radius of 283 .00 feet, a distance of 119.02 feet to the division line between Lot 7 and Lot 8 on said map;

 

THENCE along said division line, the following two (2) courses and distances:

1). North 55 degrees 08 minutes 36 seconds West, 129.29 feet;

2). North 11 degrees 47 minutes 48 seconds West, 348.01 feet to a point on the southerly line of "Map of College Woods Section 2", filed 3/4/91 as Map No. 9071.

 

THENCE along said southerly line of "Map of College Woods, Section 2", North 72 degrees 54 minutes 33 seconds East, a distance of 1106.21 feet to a point;

 

THENCE South 39 degrees 24 minutes 19 seconds East, a distance of 136.64 feet to a point on the westerly line of North Champlin Drive;

 

THENCE along westerly line of North Champlin Drive, the following four (4) courses and distances:

1). South 13 degrees 29 minutes 54 seconds East, a distance of 137.77 feet to point;

2). Along the arc of a curve, bearing to the right having a radius of 975.00 feet, a distance of 85.23 feet to a point;

3). South 08 degrees 29 minutes 23 seconds East, a distance of 148.26 feet to a point;

4). Along the arc of a curve, bearing to the right, having a radius of 25 . 00 feet, a distance of 39.27 feet to the point or place of BEGINNING.

 

TOGETHER with a non-exclusive easement for ingress and egress, in and over described parcel:

 

ALL that certain plot, piece or parcel of land, situate, lying and being in Central Islip in the Town of Islip, County of Suffolk and State of New York, being a portion of Lot 4 on a certain map entitled, Map of Tech Park" filed in the Office of the Clerk of the County of Suffolk, filed October 30, 1992 as Map No. 9282, being more particularly bounded and described as follows:

 

 

 

BEGINNING at a point on the westerly side of North Champlin Drive where the same is intersected by the division line between Lot 4 and Lot 5 on said map;

 

RUNNING THENCE along the westerly side of North Champlin Drive, North 13 degrees, 29 minutes 54 seconds West, 126.66 feet to a point;

 

THENCE through Lot 4 on said map, South 72 degrees 54 minutes 33 seconds West, 59.82 feet to a point on the division line between Lot 4 and Lot 5 on said map;

 

THENCE along the division line, South 39 degrees 24 minutes 19 seconds East, 136.64 feet to the point or place of BEGINNING.

 

Premises commonly known as 555 N Research Place, Central Islip, New York 11722.

 

 

 

EXHIBIT D

 

Form of Assignment Agreement

 

 

ASSIGNMENT AND ASSUMPTION AGREEMENT

THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Assignment”), dated this ____ day of _________, 2021, is made by and between 555 N RESEARCH CORPORATION (the “Assignor”) and ___________________________________ (the “Assignee”).

 

WHEREAS, Assignee has this day purchased Assignor’s interest in the real property known as 555 N. Research Place, Central, Islip, NY 11722 (the “Property”); and

 

WHEREAS, Assignor is landlord under all those certain leases described on Schedule A attached hereto and made a part hereof (“Leases”); and

 

WHEREAS, Assignor desires to assign to Assignee, and Assignee desires to accept the assignment from Assignor of all of Assignor’s right, title and interest in and to the Leases.

 

NOW, THEREFORE, in consideration of the mutual covenants and conditions contained herein, the parties hereto, intending to be legally bound hereby, covenant and agree as follows:

 

1.         Assignor hereby transfers, assigns, conveys and sets over unto Assignee without representation, recourse or warranty of any kind, whether statutory, express or implied, all of Assignor’s right, title and interest in and to the Leases, including, without limitation, all of Assignor’s right, title and interest in and to the rents due thereunder and to the security deposits listed on Schedule A. Assignor acknowledges and agrees that there are no advance rents held by Assignor under the Lease.

 

2         Assignee hereby accepts the foregoing assignment and agrees to assume, keep, perform and fulfill all of the terms, conditions and obligations which are required to be kept, performed and fulfilled by Assignor under the Leases from and after the date hereof and acknowledges receipt of the security deposits listed on Schedule A.

 

3.         Assignee agrees to indemnify, protect, hold harmless and defend Assignor from and against any and all claims, demands, liabilities, losses, costs, obligations, injuries, penalties, causes of action, damages, expenses, including, without limitation, reasonable attorneys’ fees, charges and disbursements through all appeals (including, without limitation, reasonable attorneys’ fees and disbursements through all appeals in the collection thereof) asserted against or suffered by Assignor in connection with, related to, arising from, or resulting from, directly or indirectly, the security deposits listed on Schedule A or claims made by Tenants with respect to any failure of Purchaser to perform its obligations arising and/or accruing from and after the date hereof.

 

Exhibit D - 1

 

4.         The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 

5.         This Assignment may be signed in multiple counterparts which, when taken together and signed by all parties and delivered to any other party hereto, shall constitute a binding Assignment and Assumption between the parties.

 

IN WITNESS WHEREOF, the parties have executed this Assignment as of the date first written above.

 

 

 

ASSIGNOR:

   
 

555 N RESEARCH CORPORATION

   
   
 

By: __________________________

 

Name:

 

Title:

   
   
 

ASSIGNEE:

   
 

[________________]

   
   
 

By: __________________________

 

Name:

 

Title:

 

 

 

Schedule A

 

 

1.

Lease dated November 23, 2020 (the “Eastside Lease”) by and between the Seller, as landlord, and Elm Freight Handlers Inc., D/B/A Elm Global Logistics, as tenant.

Security Deposit $ [$66,666.66]

 

 

2.

Lease dated May 31, 2019, as extended by notice of the exercise of the second lease option from tenant Seller dated November 19, 2020, (the “Westside Lease”), by and between Seller, as landlord, and Elm Freight Handlers Inc., D/B/A Elm Global Logistics, as tenant.

Security Deposit $ [$71,250.00]

 

 

 

EXHIBIT E

 

Form of Notice to Tenants

555 N Research Corporation

355 South Technology Drive

Central Islip, NY 11722

 

 

 

                 ____________, 2021

 

Elm Freight Handlers, Inc.

DBA Elm Global Logistics

555 N. Research Place

Central Islip, NY 11722

 

Re:         555 North Research Place, Central Islip, NY 11722

 

 

Dear Tenant:

This is to notify you that, today, the referenced property has been acquired by [______________] (“Purchaser”). As of the date hereof, your lease dated ______________, for the EAST SIDE premises, together with your security deposit in the amount of $____________ has been assigned to Purchaser.

 

You are hereby authorized and directed to make all future rent payments to Purchaser, at ________________________________________________. Any future inquiries regarding your lease should be directed to ____________ at the aforementioned address. Please update the insurance policies carried by you under your lease to delete the current landlord entity and its affiliates, and to add Purchaser as an additional insured thereunder and please deliver certificates evidencing the revised coverage promptly to Purchaser at the aforementioned address.

 

 

Very truly yours,

   
 

555 N RESEARCH CORPORATION

   
   
 

By: __________________________

 

Name:

 

Title:

 

 

 

 

555 N Research Corporation

355 South Technology Drive

Central Islip, NY 11722

 

 

 

            ____________, 2021

 

Elm Freight Handlers, Inc.

DBA Elm Global Logistics

555 N. Research Place

Central Islip, NY 11722

 

Re:         555 North Research Place, Central Islip, NY 11722

 

 

Dear Tenant:

 

This is to notify you that, today, the referenced property has been acquired by [______________] (“Purchaser”). As of the date hereof, your lease dated ______________, for the WEST SIDE premises, together with your security deposit in the amount of $____________ has been assigned to Purchaser.

 

You are hereby authorized and directed to make all future rent payments to Purchaser, at ________________________________________________. Any future inquiries regarding your lease should be directed to ____________ at the aforementioned address. Please update the insurance policies carried by you under your lease to delete the current landlord entity and its affiliates, and to add Purchaser as an additional insured thereunder and please deliver certificates evidencing the revised coverage promptly to Purchaser at the aforementioned address.

 

 

Very truly yours,

   
 

555 N RESEARCH CORPORATION

   
   
 

By: __________________________

 

Name:

 

Title:

 

 

 

EXHIBIT F

FORM OF OWNERS CERTIFICATE

 

File # _______________

 

Title Certificate made this ______ day of __________, 2021 by 555 N Research Corporation (the “Company”).

 

1.    The undersigned is the __________ of the Company. The Company is the owner of the premises known as 555 North Reassert Place, Central Islip, NY 11722 (the “Premises”).

 

2.    No work has been done upon the Premises by or at the request of the Company, which will result in liens against the Premises.

 

3.    There are no judgments, federal or state tax liens, or other liens, judgments or claims assessed or filed against the Company constituting liens against the Premises.

 

4.    The Company has no actual knowledge of any proceeding in bankruptcy that is pending by or against the Company in any court.

 

5.    There no outstanding mortgages made by the Company affecting the Premises except for the mortgage made by the Company to HSBC Bank USA dated November 1, 2017 and recorded on ___________, in Liber _______, Page ______, which is being paid in full by the Company simultaneously with Closing.

 

6.    The Company is not a wholesaler or retailer of perishable agricultural commodities, produce, poultry, poultry products, livestock or meat products.

 

7.    As used in this Certificate, the term “actual knowledge” means the actual present knowledge, and not any imputed knowledge, of ________________, without investigation.

 

8.    The undersigned is executing this Certificate solely in his capacity as _______________ of the Company and shall not have any liability or obligation in connection with this Certificate.

 

[The balance of this page is intentionally left blank.]

 

 

 

 

This Certificate is given to _____________ Title Insurance Company this __ day of ____, 2021, knowing that said company will rely on its truthfulness in connection with insuring title to the Premises.

 

555 N Research Corporation

 

By: ___________________________

Name:

Title:

 

 

 

 

EXHIBIT G

 

 

Tenant Estoppel Certificate

 

The undersigned (“Tenant”) hereby certifies to 555 N Research Corporation (“Landlord”) and to any mortgagee or purchaser of the real property commonly known as 555 N. Research Place, Central Islip, New York 11722 (the “Property”), as follows:

 

(1)    Tenant is the tenant under that certain lease dated November 23, 2020 (the “Lease”), covering an area of +/- 40,0000 square feet on the East Side of the building on the Property (the “Demised Premises”), as more particularly described in the Lease.

 

(2)    A true, complete and correct copy of the Lease is annexed hereto. Except for the Lease, there are no agreements between Tenant and Landlord in respect of the Demised Premises.

 

(3)    The Lease has not been amended or modified and is in full force and effect.

 

(4)     Neither Landlord nor Tenant is in default under the Lease.

 

(5)    The term of the Lease commenced on January 1, 2021 and will end on June 30, 2022, subject to the following renewal option, unless sooner terminated as provided in the Lease: Tenant has two (2) consecutive options to renew the Lease, each for additional period of one (1) year.

 

(6)    The amount of the annual base rental currently payable under the Lease is $400,000.00, subject to increase as set forth in the Lease. Tenant has not made any prepayment of rent under the Lease more than one month in advance. All base rent been paid through March 31, 2021.

 

(7)    A security deposit in the amount of $66,666.66 was paid upon commencement of the Lease.

 

(8)    Tenant has no option or right of first refusal to purchase the Property or to expand the Demised Premises.

 

(9)    This Certificate shall inure to the benefit of Landlord, its successors and assigns, and any mortgagee or purchaser of the Property. This Certificate shall not be deemed to alter or modify any of the terms and conditions of the Lease.

 

(10)    Facsimile and electronic signatures of Tenant, and signatures transmitted in .pdf format, shall be deemed to be original signatures.

 

IN WITNESS WHEREOF, the undersigned has caused this Certificate to be duly executed and delivered on this __________ day of __________, 2021.

 

 

TENANT:

   
 

Elm Freight Handlers Inc.,

 

D/B/A Elm Global Logistics

   
   
 

By: __________________________________________

                                                          

 

 

 

STATE OF NEW YORK )
  ) ss.:
COUNTY OF ____________   )

 

On the ____ day of______ 2021 before me, the undersigned, personally appeared ____________________ personally known to me or proved to me on the basis of satisfactory evidence to be the individual(s) whose name(s) is (are) subscribed to the within instrument and acknowledged to me that he/she/they executed the same in his/her/their capacity(ies), and that by his/her/their signature(s) on the instrument, the individual(s), or the person(s) on behalf of which the individual(s) acted, executed the instrument.

 

  ________________________________
  Notary Public

 

 

 

 

Tenant Estoppel Certificate

 

The undersigned (“Tenant”) hereby certifies to 555 N Research Corporation (“Landlord”) and to any mortgagee or purchaser of the real property commonly known as 555 N. Research Place, Central Islip, New York 11722 (the “Property”), as follows:

 

(1)    Tenant is the tenant under that certain lease dated May 31, 2019, as extended pursuant to a certain Exercise of Lease Option dated November 19, 2020 (collectively the “Lease”), covering an area of +/- 45,0000 square feet on the West Side of the building on the Property (the “Demised Premises”), as more particularly described in the Lease.

 

(2)    A true, complete and correct copy of the Lease is annexed hereto. Except for the Lease, there are no agreements between Tenant and Landlord in respect of the Demised Premises.

 

(3)    The Lease has not been amended or modified and is in full force and effect.

 

(4)     Neither Landlord nor Tenant is in default under the Lease.

 

(5)    The term of the Lease commenced on June 1, 2019 and will end on June 30, 2022, subject to the following renewal option, unless sooner terminated as provided in the Lease. Tenant had four (4) consecutive options to renew the Lease, each for additional period of one (1) year (each a “Renewal Option”). Tenant exercised the first two (2) Renewal Options and has two (2) Renewal Options remaining.

 

(6)    The amount of the annual base rental currently payable under the Lease is $440,325.00, subject to increase as set forth in the Lease. Tenant has not made any prepayment of rent under the Lease more than one month in advance. All base rent been paid through March 31, 2021.

 

(7)    A security deposit in the amount of $71,250.00 was paid upon commencement of the Lease, and an additional security deposit in the amount of $2,137.50 is now due.

 

(8)    Tenant has no option or right of first refusal to purchase the Property or to expand the Demised Premises.

 

(9)    This Certificate shall inure to the benefit of Landlord, its successors and assigns, and any mortgagee or purchaser of the Property. This Certificate shall not be deemed to alter or modify any of the terms and conditions of the Lease.

 

(10)    Facsimile and electronic signatures of Tenant, and signatures transmitted in .pdf format, shall be deemed to be original signatures.

 

IN WITNESS WHEREOF, the undersigned has caused this Certificate to be duly executed and delivered on this _______ day of _______, 2021.

 

 

TENANT:

 

Elm Freight Handlers Inc.,

 

D/B/A Elm Global Logistics

   
   
 

By: __________________________________________

 

 

 

STATE OF NEW YORK )
  ) ss.:
COUNTY OF ____________   )

 

On the ____ day of _______, 2021 before me, the undersigned, personally appeared ________________________personally known to me or proved to me on the basis of satisfactory evidence to be the individual(s) whose name(s) is (are) subscribed to the within instrument and acknowledged to me that he/she/they executed the same in his/her/their capacity(ies), and that by his/her/their signature(s) on the instrument, the individual(s), or the person(s) on behalf of which the individual(s) acted, executed the instrument.

 

 

  ________________________________
  Notary Public

 

 

Exhibit 31.1

Certifications of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Emmanuel Lakios, certify that:

 

 

1.

I have reviewed this quarterly report on Form 10-Q of CVD Equipment Corporation;

 

 

2.

Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 13, 2021

 

  /s/ Emmanuel Lakios

----------------------------------------

President, Chief Executive Officer

 

 

Exhibit 31.2

Certifications of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Thomas McNeill, certify that:

 

 

1.

I have reviewed this quarterly report on Form 10-Q of CVD Equipment Corporation;

 

 

2.

Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Dated: May 13, 2021

 

  /s/ Thomas McNeill

----------------------------------------

Thomas McNeill

Chief Financial Officer

(Principal Financial Officer)

 

 

 

Exhibit 32.1

 

Certification of Principal Executive Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

I, Emmanuel Lakios, President and Chief Executive Officer of CVD Equipment Corporation, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending March 31, 2021 of CVD Equipment Corporation (the “Form 10-Q") fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of CVD Equipment Corporation.

 

 

Dated: May 13, 2021

/s/   Emmanuel Lakios

 

Emmanuel Lakios

 

Chief Executive Officer

 

(Principal Executive Officer)

 

 

 

Exhibit 32.2

 

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

I, Thomas McNeill, Chief Financial Officer of CVD Equipment Corporation, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending March 31, 2021 of CVD Equipment Corporation (the “Form 10-Q") fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of CVD Equipment Corporation.

 

 

Dated: May 13, 2021

/s/   Thomas McNeill

 

Thomas McNeill

 

Chief Financial Officer

 

(Principal Financial Officer)